News Room

18th April 2019
Copy of Notice published in newspapers regarding loss of Share Certificates
Copy of Notice published in newspapers regarding loss of Share Certificates
Press Release

17th April 2019
INTIMATION OF LOST SHARE CERTIFICATE/ISSUE OF DUPLICATE SHARE CERTIFICATE
INTIMATION OF LOST SHARE CERTIFICATE/ISSUE OF DUPLICATE SHARE CERTIFICATE
Press Release

15th April 2019
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
Press Release

13th April 2019
INTIMATION OF LOST SHARE CERTIFICATE/ISSUE OF DUPLICATE SHARE CERTIFICATE
INTIMATION OF LOST SHARE CERTIFICATE/ISSUE OF DUPLICATE SHARE CERTIFICATE
Press Release

13th April 2019
Copy of Notice published in newspapers regarding loss of Share Certificates
Copy of Notice published in newspapers regarding loss of Share Certificates
Press Release

12th April 2019
INTIMATION OF LOST SHARE CERTIFICATE/ISSUE OF DUPLICATE SHARE CERTIFICATE
INTIMATION OF LOST SHARE CERTIFICATE/ISSUE OF DUPLICATE SHARE CERTIFICATE
Press Release

6th April 2019
Copy of Notice published in newspapers regarding loss of Share Certificates
Copy of Notice published in newspapers regarding loss of Share Certificates
Press Release

3rd April 2019
Notice of closure of trading window
We hereby inform that in accordance with the Code of Conduct to Regulate, Monitor and Reporting of T
Press Release

3rd April 2019
Intimation of lost share certificate/issue of duplicate share certificate
Intimation of lost share certificate/issue of duplicate share certificate
Press Release

30th March 2019
Outcome of the Allotment Committee of the Board held on 30 March 2019
Outcome of the Allotment Committee of the Board held on 30 March 2019
Press Release

30th March 2019
Outcome of the Allotment Committee of the Board held on 30 March 2019
Outcome of the Allotment Committee of the Board held on 30 March 2019
Press Release

29th March 2019
Outcome of the meeting of Independent Directors held on 29 March 2019
Outcome of the meeting of Independent Directors held on 29 March 2019
Press Release

29th March 2019
Update
Press Release

26th March 2019
Copy of Notice published in newspapers regarding loss of Share Certificates
Copy of Notice published in newspapers regarding loss of Share Certificates
Press Release

25th March 2019
Intimation of lost share certificate/issue of duplicate share certificate
Intimation of lost share certificate/issue of duplicate share certificate
Press Release

18th March 2019
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATE
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATE
Press Release

13th March 2019
Proceedings of the Extra-ordinary General Meeting of the Company held on 13 March 2019
Proceedings of the Extra-ordinary General Meeting of the Company held on 13 March 2019 Extra-ordi
Press Release

13th March 2019
Copy of Notice published in newspapers regarding loss of share certificate
Copy of Notice published in newspapers regarding loss of share certificate
Press Release

13th March 2019
Scrutinizer Report of Extra-ordinary General Meeting of the Company held on 13 March 2019
Scrutinizer Report of Extra-ordinary General Meeting of the Company held on 13 March 2019
Press Release

12th March 2019
Intimation of lost share certificate/issue of duplicate share certificate
Intimation of lost share certificate/issue of duplicate share certificate
Press Release

9th March 2019
Copy of Notice published in newspapers regarding loss of Share Certificates
Copy of Notice published in newspapers regarding loss of Share Certificates
Press Release

8th March 2019
Copy of Notice published in newspapers regarding loss of Share Certificate
Copy of Notice published in newspapers regarding loss of Share Certificate
Press Release

8th March 2019
08 March 2019 Intimation of lost share certificate/issue of duplicate share certificate
08 March 2019 Intimation of lost share certificate/issue of duplicate share certificate
Press Release

6th March 2019
Intimation of lost share certificate/issue of duplicate share certificate
Intimation of lost share certificate/issue of duplicate share certificate
Press Release

2nd March 2019
Copy of Notice published in newspapers regarding loss of Share Certificate
Copy of Notice published in newspapers regarding loss of Share Certificate
Press Release

1st March 2019
Intimation of lost share certificate/issue of duplicate share certificate
Intimation of lost share certificate/issue of duplicate share certificate
Press Release

25th February 2019
Copy of Notice published in newspapers regarding loss of Share Certificate
Copy of Notice published in newspapers regarding loss of Share Certificate
Press Release

23rd February 2019
Intimation of lost share certificate/issue of duplicate share certificate
Intimation of lost share certificate/issue of duplicate share certificate
Press Release

18th February 2019
SUBMISSION OF NEWSPAPER CUTTING OF NOTICE OF EXTRA-ORDINARY GENERAL MEETING AND E-VOTING INFORMATION
SUBMISSION OF NEWSPAPER CUTTING OF NOTICE OF EXTRA-ORDINARY GENERAL MEETING AND E-VOTING INFORMATION
Press Release

16th February 2019
Notice of Extra-ordinary General Meeting (EOGM) to be held on Wednesday, 13 March
Notice of Extra-ordinary General Meeting (EOGM) to be held on Wednesday, 13 March
Press Release

14th February 2019
Submission of newspaper cutting of un-audited financial results for the quarter and nine months ende
Submission of newspaper cutting of un-audited financial results for the quarter and nine months ende
Press Release

12th February 2019
UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTH ENDED 31 DECEMBER 2018
UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTH ENDED 31 DECEMBER 2018
Press Release

12th February 2019
Press Release with respect to Financial Results for the Quarter and nine months ended 31-12-2018
Press Release

12th February 2019
Outcome of the Board Meeting held on 12 February 2019
Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20

6th February 2019
Appointment of Additional and Independent Directors
Appointment of Additional and Independent Directors 1. Appointment of Mr Rajender Mohan Malla (DI
Press Release

6th February 2019
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING NOTICE OF BOARD MEETING
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING NOTICE OF BOARD MEETING
Press Release

4th February 2019
NOTICE OF THE BOARD MEETING AND CLOSURE OF TRADING WINDOW
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Tuesday,
Press Release

28th January 2019
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES / ISSUE OF DUPLICATE SHA
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES / ISSUE OF DUPLICATE SHA
Press Release

24th January 2019
INTIMATION OF LOST OF SHARE CERTIFICATE
Press Release

1st January 2019
Credit rating
Credit rating
Press Release

29th December 2018
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
Press Release

27th December 2018
INTIMATION OF LOST OF SHARE CERTIFICATE
INTIMATION OF LOST OF SHARE CERTIFICATE
Press Release

7th December 2018
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
Press Release

6th December 2018
Intimation of Lost of Share Certificate
Intimation of Lost of Share Certificate
Press Release

3rd December 2018
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
Press Release

1st December 2018
INTIMATION OF LOST SHARE CERTIFICATES
Press Release

24th November 2018
COPY OF NOTICE PUBLISHED IN NEWSPAPERS REGARDING LOSS OF SHARE CERTIFICATES
Press Release

22nd November 2018
INTIMATION OF LOST SHARE CERTIFICATES
INTIMATION OF LOST SHARE CERTIFICATES
Press Release

16th November 2018
Submission of newspaper cutting of un-audited financial results for the quarter and half year ended
Submission of newspaper cutting of un-audited financial results for the quarter and half year ended
Press Release

14th November 2018
OUTCOME OF THE BOARD MEETING HELD ON 14 NOVEMBER 2018
Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20

14th November 2018
Un-audited financial results for the quarter and half year ended 30 September 2018
Un-audited financial results for the quarter and half year ended 30 September 2018
Press Release

14th November 2018
PRESS RELEASE FOR FINANCIAL RESULTS
Press Release with respect to Financial Results for the Quarter and half year ended 30 September 201
Press Release

8th November 2018
Intimation of sad demise of Dr M A Zahir, Chairman and Independent director of the Company
Press Release

6th November 2018
Copy of Notice published in Newspapers
Press Release

5th November 2018
NOTICE OF THE BOARD MEETING AND CLOSURE OF TRADING WINDOW
The meeting of the Board of Directors is scheduled to be held on Wednesday, the 14 November 2018 int
Press Release

1st November 2018
Copy of Notice published in newspapers regarding loss of Share Certificates
Copy of Notice published in newspapers regarding loss of Share Certificates
Press Release

30th October 2018
Intimation of lost share certificates
Intimation of lost share certificates
Press Release

6th October 2018
Amended Memorandum and Articles of Association
Amended Memorandum and Articles of Association
Press Release

29th September 2018
Proceedings of the 31st Annual General Meeting of the Company
Proceedings of the 31st Annual General Meeting of the Company held on 29 September 2018
Press Release

29th September 2018
Voting Results and Scrutinizer Report of 31st Annual General Meeting of the Company
Voting Results and Scrutinizer Report of 31st Annual General Meeting of the Company held on 29 Septe
Press Release

8th September 2018
Copy of Notice published regarding loss of Share Certificates
Copy of Notice regarding loss of Share Certificate published on 08 September 2018 in ‘Economic Times
Press Release

7th September 2018
Intimation of lost share certificate
Under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosur
Press Release

5th September 2018
Notice published in newspaper
Submission of copies of newspaper advertisements for 31st Annual General Meeting (AGM) / Book Closu
Press Release

1st September 2018
NOTICE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE
This is to inform you that 31th Annual General Meeting of the Company is scheduled to be held on Sat
Press Release

11th August 2018
Outcome of the Board Meeting
Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20

11th August 2018
Un-audited financial results for the quarter ended 30 June 2018
Un-audited financial results for the quarter ended 30 June 2018
Press Release

11th August 2018
PRESS RELEASE FOR FINANCIAL RESULTS For THE QUARTER ENDED 30 JUNE 2018
PRESS RELEASE FOR FINANCIAL RESULTS For THE QUARTER ENDED 30 JUNE 2018
Press Release

31st July 2018
NOTICE OF THE BOARD MEETING
the meeting of the Board of Directors is scheduled to be held on Saturday, the 11 August 2018 inter-

16th May 2018
PRESS RELEASE FOR FINANCIAL RESULTS
Press Release with respect to Financial Results for the Quarter and Financial Year ended on 31 March
Press Release

16th May 2018
FINANCIAL RESULTS 31 MARCH 2018 AND OUTCOME OF THE BOARD MEETING HELD ON 16 MAY 2018.
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulati
Press Release

7th May 2018
Notice of the Board Meeting
The meeting of the Board of Directors is scheduled to be held on Wednesday, the 16 May 2018 inter-al

3rd April 2018
Announcement under Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015
This is to inform you that our Statutory Auditors, M/s S.C. Vasudeva & Co., Chartered Accountants ha
Press Release

12th February 2018
FINANCIAL RESULT 31 DECEMBER 2017 AND OUTCOME OF THE BOARD MEETING HELD ON 12 FEBRUARY 2018.
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulati
Press Release

12th February 2018
Press Release for Financial Results and successfully completed unit IV to manufacture Metformin, an
Press Release for Financial Results and successfully completed unit IV to manufacture Metformin, an
Press Release

12th February 2018
Outcome of the meeting of Independent Directors held on 12 February 2018
We wish to inform you that the Independent Directors in their meeting held on today i.e. 12 February
Press Release

3rd February 2018
03 February 2018 NOTICE OF BOARD MEETING
The meeting of the Board of Directors is scheduled to be held on Monday, the 12 February 2018 inter-

13th November 2017
FINANCIAL RESULT 30 SEPTEMBER 2017 AND OUTCOME OF THE BOARD MEETING HELD ON 13 NOVEMBER 2017
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulati
Press Release

13th November 2017
Press release for Financial Results for the quarter and half year ended 30 September 2017 and to inv
Press Release

6th November 2017
Notice of Board Meeting
The meeting of the Board of Directors is scheduled to be held on Monday, the 13th day of November, 2

29th September 2017
Voting Results of 30th Annual General Meeting of the Company held on 28 September 2017
Press Release

28th September 2017
Proceedings of the 30th Annual General Meeting of the Company held on 28 September 2017
The 30th Annual General Meeting of the Company was held on Thursday, 28 September 2017 at 11:00 AM –

5th September 2017
Notice published in newspaper
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015
Press Release

1st September 2017
Notice of Annual General Meeting and Book Closure
Dear Sir, This is to inform you that 30th Annual General Meeting of the Company is scheduled to b

18th August 2017
Financial Result 30.06.2017 and Outcome of the Board Meeting held on 18 August 2017
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulati
Press Release

18th August 2017
Press Release for Financial Result for the quarter ended 30 June.2017
Press Release

10th August 2017
Notice of the Board Meeting
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Friday,

29th May 2017
Financial Results published in the newspaper
This is with reference to the extract of audited financial results for the quarter / year ended 31 M
Press Release

27th May 2017
Financial Result 31.03.2017 and Outcome of the Board Meeting held on 27 May 2017
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulati
Press Release

20th May 2017
Notice of the Board Meeting
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Saturday

12th April 2017
EUGMP Certification from National Institute of Pharmacy and Nutrition, Hungary
The company has received EUGMP Certification from National Institute of Pharmacy and Nutrition, Hun

11th February 2017
UN-AUDITED FINANCIAL RESULTS FOR QUARTER AND NINE MONTH ENDED 31 DECEMBER 2016
The Board of Directors in its meeting held on 11 February 2017 had approved the Un-audited Financial
Press Release

11th February 2017
Outcome of the meeting of Independent Directors held on 11 February 2017
The Independent Directors in their meeting held on today i.e. 11 February 2017 inter-alia reviewed

31st January 2017
NOTICE OF THE BOARD MEETING
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Saturday

4th January 2017
Credit rating
Pursuant to Regulation 30 and any other provisions of the SEBI (Listing Obligations and Disclosure R

15th December 2016
National Energy Conservation Award - 2016
The Company has won the National Energy Conservation Award - 2016. The company has awarded with the

7th November 2016
UN-AUDITED FINANCIAL RESULTS FOR QUARTER /HALF YEAR ENDED 30 SEPTEMBER 2016
The Board of Directors in its meeting held on 07 November 2016 had approved the Un-audited Financial
Press Release

1st November 2016
Analysis Report on the Company by IIFL Wealth Management Limited
Analysis Report on the Company by IIFL Wealth Management Limited
Press Release

29th October 2016
Notice of the Board Meeting
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Monday,

29th September 2016
Voting Results of 29th Annual General Meeting of the Company held on 28 September 2016
Under Regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
Press Release

28th September 2016
Proceedings of the 29th Annual General Meeting of the Company held on 28 September 2016​
This is to inform you that the 29th Annual General Meeting of the Company was held on Wednesday, 28
Press Release

6th September 2016
Notice published in newspaper
This is to inform you that the Notice of the 29th Annual General Meeting containing the detail and m
Press Release

1st September 2016
Notice of Annual General Meeting and Book Closure
This is to inform you that 29th Annual General Meeting of the Company is scheduled to be held on Wed
Press Release

8th August 2016
Un-audited Financial Results 30.06.2016
The Board of Directors in its meeting held on 08 August 2016 had approved the Un-audited Financ
Press Release

30th July 2016
Notice of Board Meeting
The meeting of the Board of Directors is scheduled to be held on Monday, the 08th day of August, 201

14th June 2016
NOTICE U/S. 201 OF THE COMPANIES ACT, 2013- NEWSPAPER CLIPPINGS 14 June 2016
This is to inform you that the Company proposes to make applications to the Central Government for i
Press Release

14th May 2016
Outcome of the Board Meeting held on 14 May 2016
This is to inform you that Mr Yogesh Goel, Independent Director and Mr Ravi Pratap Singh, Independen

2nd May 2016
financial results 31.03.2016
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulati
Press Release

2nd May 2016
press release regarding financial results 31 March 2016
Press Release

25th April 2016
Notice of Board Meeting
The meeting of the Board of Directors is scheduled to be held on Monday, the 02nd day of May, 2016 i
Press Release

12th April 2016
NOTICE U/S. 201 OF THE COMPANIES ACT, 2013- NEWSPAPER CLIPPINGS​
The Company proposes to make a application to the Central Government for its approval under Section
Press Release

29th March 2016
Outcome of the meeting of Independent Directors held on 29 March 2016
The Independent Directors in their meeting held on today i.e. ​29 March 2016 inter-alia revie

3rd March 2016
Credit Rating
Pursuant to Regulation 83(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulatio

3rd March 2016
Certificates of Pharmaceuticals Products (COPP) confirming WHO guidelines
The company has received "Certificates of Pharmaceuticals Products" (COPP) for manufacturing facili

30th January 2016
Un-audited financial results for the quarter ended 31 December 2015
Pursuant to the provision of requlation 33 of SEBI(listing Obligations and Disclosure Requirements)
Press Release

30th January 2016
Outcome of the Board Meeting held on 30 January 2016
The Board of Directors in its meeting held on today i.e. 30 January 2016 has considered and approve

20th January 2016
NOTICE OF BOARD MEETING
The meeting of the Board of Directors is scheduled to be held on Saturday, the 30th day of January,
Press Release

18th December 2015
Change in address of Registrar and Share Transfer Agent(RTA)
The Company Registrar and Share Transfer Agent "M/s Alankit Assignments Limited" has communicated re

30th November 2015
Outcome of Allotment Committee​ Meeting
The Allotment Committee of the Board of Directors in its meeting held on 30 November 2015 has allott

27th November 2015
Outcome of Allotment Committee Meeting
The Allotment Committee of the Board of Directors in its meeting held on 27 November 2015 has allott

24th November 2015
Outcome of the Allotment Committee of the Board held on 24 November 2015
The Allotment Committee of the Board of Directors in its meeting held on 24 November 2015 has allott

19th November 2015
IOL Chemicals and Pharmaceuticals Limited completed its De-bottlenecking/ Re-engineering project
The Company has completed its De-bottlenecking/ Re-engineering project for its Ibuprofen manufacturi
Press Release

30th October 2015
Outcome of the Board Meeting held on 30 October 2015
The Board of Directors in its meeting held on today i.e. 30 October 2015 has approved the ​U

30th October 2015
Un-audited financial results for the quarter ended 30 September 2015
Pursuant to Clause 41 of the Listing Agreement, we are enclosing herewith copy of the Un-audited fi
Press Release

29th October 2015
Outcome of the Allotment Committee
The Allotment Committee of the Board of Directors in its meeting held on 29 October 2015 has allotte

21st October 2015
Outcome of the Allotment Committee of the Board held on 21 October 2015
The Allotment Committee of the Board of Directors in its meeting held on 21 October 2015 has allotte

21st October 2015
Notice of the Board Meeting
This is to inform you that the meeting of the Board of Directors convened to be held on Saturday,31

19th October 2015
Notice of Board Meeting
The meeting of the Board of Directors is scheduled to be held on Saturday, the 31st day of October,
Press Release

15th October 2015
Minutes of the 28th Annual General Meeting held on 29 September 2015
Pursuant to Clause 31 of the Listing Agreement, please find enclosed herewith the minutes of the 28t
Press Release

9th October 2015
Outcome of Allotment Committee
The Allotment Committee of the Board of Directors in its meeting held on 09 October 2015 has allotte

30th September 2015
Details of voting results of AGM Under Clause 35-A of Listing Agreement
Pursuant to Clause 35A of the Listing Agreement, please find enclosed herewith the details regarding
Press Release

29th September 2015
Outcome of the Annual General Meeting Held on 29 September 2015
Press Release

4th September 2015
Notice of 28th Annual General Meeting
Press Release

4th September 2015
04 September 2015 Notice of Annual General Meeting and Book Closure.
This is to inform you that 28th Annual General Meeting of the Company is scheduled to be held on Tue
Press Release

25th August 2015
Outcome of Allotment Committee
This is to inform you that the Allotment Committee of the Board of Directors in its meeting held on

20th August 2015
Outcome of Allotment Committee
This is to inform you that the Allotment Committee of the Board of Directors in its meeting held on

18th August 2015
Outcome of Allotment Committee
The Allotment Committee of the Board of Directors in its meeting held on 18 August 2015 has allotted

13th August 2015
Outcome of the Board Meeting held on 13 August 2015
The Board of Directors in its meeting held on today i.e. 13 August 2015 has considered and approve

5th August 2015
Outcome of Allotment Committee
The Allotment Committee of the Board of Directors in its meeting held on 05 August 2015 has allotted
Press Release

4th August 2015
Notice of Board Meeting and Close the Trading Window
The meeting of the Board of Directors is scheduled to be held on Thursday, the 13th day of August, 2

20th July 2015
20 July 2015 Opening of US market for IOLCP
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has received from US Food and Drug Administration
Press Release

13th July 2015
Notice U/s 201 of Companies Act 2013 - Newspaper Clippings​
The Company proposes to make three applications to the Central Government for its approval under Sec
Press Release

3rd July 2015
Outcome of the Allotment Committee Meeting
The Allotment Committee of the Board of Directors in its meeting held on 03 July 2015 has allotted 5

1st July 2015
Renewal of "HALAL CERTIFICATE" for the year 2015-16
The Company has got renewal of "HALAL CERTIFICATE" from Halal Committee, Jamiat Ulama - E - Maharash

29th June 2015
Outcome of the Allotment Committee of the Board held on 29 June 2015
The Allotment Committee of the Board of Directors in its meeting held on 29 June 2015 has allotted 8

10th June 2015
OUTCOME OF THE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 10 JUNE 2015
The Allotment Committee of the Board of Directors in its meeting held on 10 June 2015 has allotted 5

29th May 2015
Outcome of Board Meeting 29 May 2015
The Board of Directors in its meeting held on today i.e. 29 May 2015 has considered and approved the

27th May 2015
Outcome of the Allotment Committee of the Board held on 27 May 2015
The Allotment Committee of the Board of Directors in its meeting held on 27 May 2015 has allotted 5,

12th May 2015
Outcome of Allotment Committee Meeting
The Allotment Committee of the Board of Directors in its meeting held on 12 May 2015 has allotted 5,

5th May 2015
CEP certification for product Metformin Hydrochloride by EDQM
The company has been awarded with CEP certification (Certificates of Suitability) dated April 17, 20

1st April 2015
Disclosure of trading window closed
As per the Company's Code of Conduct for Prohibition of Insider Trading framed pursuant to the Secur

30th March 2015
Outcome of the meeting of Independent Directors
The Independent Directors in their meeting held on today i.e. 30 March 2015 inter-alia evaluated t

13th February 2015
Outcome of Board Meeting
The Board of Directors in its meeting held on today i.e. 13 February 2015 has approved the Un-audite

6th February 2015
06 February 2015 Clarification
This has reference to the mail received 06 February 2015 from ET NOW regarding the rumour about the

5th February 2015
Notice of the Board Meeting
The meeting of the Board of Directors is scheduled to be held on Friday, the 13th day of February, 2

28th November 2014
Outcome of the Board Meeting 28 November 2014
The Board of Directors in its meeting held on today i.e. 28 November 2014 has considered and approve

21st November 2014
Deny news article that appeared in Economic Times
We refer to the news article that appeared today i.e. 21.11.2014 in a leading business daily Economi

18th November 2014
Notice of the Board Meeting 18 November 2014
The meeting of the Board of Directors is scheduled to be held on Friday, the 28th day of November, 2

18th November 2014
Outcome of the Allotment Committee 18 November 2014
The Allotment Committee of the Board of Directors in its meeting held on 18 November 2014 allotted 7

14th November 2014
Outcome of the Allotment Committee Meeting 14 November 2014
The Allotment Committee of the Board of Directors in its meeting held on 14 November 2014 allotted 1

13th November 2014
Outcome of the Allotment Committee Meeting 13 November 2014
The Allotment Committee of the Board of Directors in its meeting held on 13 November 2014 allotted 7

29th October 2014
OUTCOME OF THE BOARD MEETING HELD ON 29 OCTOBER 2014
The Board of Directors in its meeting held on today i.e. 29 October 2014 has considered and approved

27th October 2014
Notice of Board Meeting​
The meeting of the Board of Directors is scheduled to be held on Wednesday, the 29th day of October,

30th September 2014
OUTCOME OF THE ANNUAL GENERAL MEETING HELD ON 30 SEPTEMBER 2014
That the members of the Company in its Annual General Meeting held on 30 September 2014 at the Regis
Press Release

30th September 2014
DECLARATION OF RESULT BY CHAIRMAN OF AGM AND SCRUTINIZER REPORT​ 30 SEPTEMBER 2014
Press Release

6th September 2014
06 September 2014 Notice in newspaper
The Notice of the Annual General Meeting containing the detail and manner of electronic voting toget
Press Release

2nd September 2014
27 th Annual General Meeting
27th Annual General Meeting of the Company is scheduled to be held on Thuseday, 30 September 2014 at
Press Release

22nd August 2014
Outcome of the Board Meeting held on 22 August 2014
The Board of Directors in its meeting held on today i.e. 22 August 2014 has approved the following:

22nd August 2014
Draft Letter of Appointment of Independent Director
Press Release

14th August 2014
OUTCOME OF BOARD MEETING HELD ON 14 AUGUST 2014
The Board of Directors in its meeting held on today i.e. 14 August 2014 has approved the Un-audited

31st July 2014
Notice of Board Meeting
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Thursday

4th July 2014
OUTCOME OF ALLOTMENT COMMITTEE HELD ON 04 JULY 2014 04 July 2014
The Share Allotment Committee of the Board of Directors in its meeting held on 04 July 2014 allotted

21st June 2014
OUTCOME OF ALLOTMENT COMMITTEE HELD ON 21 JUNE 2014
The Share Allotment Committee of the Board of Directors in its meeting held on 21 June 2014 allotted

20th June 2014
Outcome of the Extra-ordinary General Meeting of the Company
An Extraordinary General meeting of members was held today June 20,2014 at Barnala and following ord

20th June 2014
Declaration of Result by Chairman of EGM
Press Release

30th May 2014
OUTCOME OF BOARD MEETING HELD ON 30 MAY 2014
The Board of Directors in its meeting held on today i.e. 30 May 2014 has considered and approved the

27th May 2014
NOTICE OF EXTRA-ORDINARY GENERAL MEETING
Notice is hereby given that the Extra- ordinary General Meeting of the Members of the Company will b
Press Release

21st May 2014
Outcome of board meeting held on 21.05.2014
The Board of Directors in its meeting held on today i.e.21 May 2014 has approved the following 1.

19th May 2014
NOTICE OF THE BOARD MEETING 21 MAY 2014
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Wednesda

15th May 2014
NOTICE OF THE BOARD MEETING 30 MAY 2014
The meeting of the Board of Directors is scheduled to be held on Friday, the 30th day of May, 2014 i

19th March 2014
Result of Postal Ballot
Press Release

17th February 2014
Newspaper Advertisement of Notice of Postal Ballot
The Company has on 15 February 2014 completed the dispatch of Postal Ballot Notice under Section 192
Press Release

15th February 2014
POSTAL BALLOT NOTICE (PURSUANT TO SECTION 192A OF THE COMPANIES ACT, 1956
The Company has on 15 February 2014 completed the dispatch of Postal Ballot Notice under Section 192
Press Release

8th February 2014
OUTCOME OF THE BOARD MEETING HELD ON 08 FEBRUARY 2014
Board of Directors in its meeting held on today i.e. 08 February 2014 has approved the following:

30th January 2014
NOTICE OF THE BOARD MEETING 08 FEBRUARY 2014
The meeting of the Board of Directors is scheduled to be held on Saturday, the 08th day of February,

17th December 2013
IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2013
Press Release

9th November 2013
OUTCOME OF THE BOARD MEETING HELD ON 09 NOVEMBER 2013
Board of Directors in its meeting held on today i.e. 09 November 2013 has approved the Un-audited fi

1st November 2013
NOTICE OF THE BOARD MEETING 09 NOVEMBER 2013
The meeting of the Board of Directors is scheduled to be held on Saturday, the 09th day of November,

3rd September 2013
NOTICE OF 26TH ANNUAL GENERAL MEETING
Notice is hereby given that the Twenty-fifth Annual General Meeting of the Members of the Company wi

12th August 2013
OUTCOME OF THE BOARD MEETING HELD ON 12 AUGUST 2013
The Board of Directors in its meeting held on today i.e.12 August 2013 has approved the following:
3rd August 2013
NOTICE OF THE BOARD MEETING 03 AUGUST 2013
The meeting of the Board of Directors is scheduled to be held on Monday, the 12th day of August, 201

18th July 2013
ABSTRACT & MEMORANDUM OF INTEREST UNDER SECTION 302 OF THE COMPANIES ACT,1956
Press Release

27th May 2013
OUTCOME OF THE BOARD MEETING HELD ON 27 May 2013
The Board of Directors in its meeting held on today i.e. 27 May 2013 has considered and approved the

18th May 2013
NOTICE OF THE BOARD MEETING 18 MAY 2013
The meeting of the Board of Directors is scheduled to be held on Monday, the 27th day of May, 2013 i

19th March 2013
Abstract & Memorandum of interest under section 302 of the Companies Act,1956
The Board of Directors of the Company, as approved by the Remuneration Committee, in its meeting hel
Press Release

4th March 2013
Appointment of Mr Vijay Kumar Garg, as Additional Director and Whole time Director
The Board of Directors has approved the appointment of Mr Vijay Kumar Garg, as Additional Director

14th February 2013
OUTCOME OF THE BOARD MEETING HELD ON 14 February 2013
Board of Directors in its meeting held on today i.e. 14 February 2013 has approved the Un-audited f

5th February 2013
NOTICE OF THE BOARD MEETING 05 FEBRUARY 2013
The meeting of the Board of Directors is scheduled to be held on Thursday, 14 February 2013 inter-al

30th January 2013
Postal Ballot Result
Press Release

22nd December 2012
POSTAL BALLOT NOTICE (Pursuant to Section 192A of the Companies Act,1956)
The Company has on 22 December 2012 completed the dispatch of Postal Ballot Notice under Section 192
Press Release

15th December 2012
IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2012
Press Release

10th November 2012
OUTCOME OF THE BOARD MEETING HELD ON 10 NOVEMBER 2012
The Board of Directors in its meeting held on today i.e. 10 November 2012 has approved the followin

31st October 2012
NOTICE OF THE BOARD MEETING
The meeting of the Board of Directors is scheduled to be held on Saturday, 10 November 2012 inter-al

30th September 2012
OUTCOME OF THE 25th ANNUAL GENERAL MEETING HELD ON 30 MAY 2012
The members of the Company in its Annual General Meeting held on 29 September 2012 at the Registered

1st September 2012
OUTCOME OF THE BOARD MEETING HELD ON 01 SEPTEMBER 2012
The Board of Directors in its meeting held on Today i.e. 01 September 2012 has approved the followi

1st September 2012
NOTICE OF 25TH ANNUAL GENERAL MEETING
Notice is hereby given that the Twenty-fifth Annual General Meeting of the Members of the Company wi

14th August 2012
OUTCOME OF THE BOARD MEETING HELD ON 14 AUGUST 2012
The Board of Directors in its meeting held on today i.e. 14 August 2012 has approved the following

30th May 2012
OUTCOME OF THE BOARD MEETING HELD ON 30 MAY 2012
Board of Directors in its meeting held on today i.e. 30 May 2012 has considered and approved the Aud

2nd May 2012
Outcome of the Share Allotment Committee of the Board held on 02 May 2012
This is to inform you that the Share Allotment Committee of the Board of Directors in its meeting he

19th April 2012
Record Date
This is to inform you that the Company has fixed 01 May 2012 as the Record Date for the purpose of d

12th April 2012
Abstract & Memorandum of Interest under section 302
The Board of Directors of Company, as approved by the Remuneration Committee, in its meeting held on
Press Release

31st March 2012
OUTCOME OF THE BOARD MEETING HELD ON 31 MARCH 2012
The Board of Directors in its meeting held on 31 March 2012 has approved the following matters:

11th February 2012
OUTCOME OF THE BOARD MEETING HELD ON 11 FEBRUARY 2012
Board of Directors in its meeting held on today i.e. 11 February 2012 has approved the Un-audited fi

15th December 2011
IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2011
Press Release

14th November 2011
Outcome of the Board Meeting held on 14 November 2011
The Board of Directors in its meeting held 14 November 2011 has approved the Un-audited financial re

24th September 2011
Outcome of the 24th Annual General Meeting held on 24 September 2011
This is to inform you that the members of the Company in its Annual General Meeting held on 24 Septe

12th August 2011
Notice of 24th Annual General Meeting
Notice is hereby given that the Twenty-forth Annual General Meeting of the Members of the Company wi

12th August 2011
OUTCOME OF THE BOARD MEETING HELD ON 12 AUGUST 2011
The Board of Directors in its meeting held 12 August 2011 has approved the Un-audited financial resu

11th July 2011
OUTCOME OF THE BOARD MEETING HELD ON 11 JULY 2011
The Board of Directors in its meeting held on 11 July 2011 has approved the following matters: 1

28th June 2011
Research & Development Recognition
IOLCP's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of S

21st May 2011
Outcome of the Board Meeting held on 21 May 2011
The Board of Directors in its meeting held on 21 May 2011 has approved the following matters: 1.

13th May 2011
Notice of the Board Meeting
The meeting of Board of Directors is scheduled to be held on Saturday, 21 May 2011 inter-alia to con

15th April 2011
Credit rating
The Credit Analysis & Research Ltd (CARE) has assigned/retained the ‘CARE BBB’ for Long Term Facilit

22nd March 2011
IOLCP assigned D&B D-U-N-S® Number : 65-004-7801
Dun & Bradstreet Information Services India Private Limited has assigned D&B D-U-N-S® Number : 65-00

8th February 2011
Outcome of the Board Meeting held on 8 February 2011
The Board of Directors in its meeting held on today i.e. 8 February 2011 has approved the Un-audited

15th December 2010
IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010
IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010
Press Release

13th November 2010
Outcome of the Board Meeting 13 November 2010
The Board of Directors in its meeting held on 13 November 2010 has approved the Un-audited financial
Press Release

23rd August 2010
Outcome of the Share Allotment Committee of the Board held on 23 August 2010
The Share Allotment Committee of the Board in its meeting held on 23 August 2010 has allotted 15,00,

14th August 2010
Outcome of the Annual General Meeting held on 14 August 2010
The members of the Company in its Annual General Meeting held on 14 August 2010 at the Registered of

11th August 2010
Outcome of the Board Meeting held on 11 August 2010
1. The Board has approved the appointment of Dr Kanwal P Pandita, as Additional Director w.e.f 16 Au

19th June 2010
Outcome of the Extra-ordinary General Meeting held on 19 June 2010
The members of the Company in its Extra-ordinary General Meeting held on 19 June 2010 at the Registe

29th May 2010
Outcome of the Board Meeting held on 29 May 2010
1. The Board of Directors in its meeting held on 29 May 2010 has approved the Annual accounts for th

28th May 2010
Outcome of the Allotment Committee Meeting held on 28 May 2010
The Allotment Committee of the Board in its meeting held on 28 May, 2010 has decided to close the FC

18th May 2010
IOLCP to raise USD 5 million through FCCB
Press Release

17th May 2010
Outcome of the Allotment Committee Meeting 17.05.2010
Allotment Committee of the Board in its meeting held on 17 May, 2010 has approved and fixed the Wedn

15th May 2010
Outcome of the Board Meeting 15.05.2010
Board of Directors in its meeting held on 15.05.2010 has approved the following matters: 1. Issue o

15th February 2010
Interview of Mr Rakesh Mahajan in CNBC-TV 18
30th January 2010
OUTCOME OF THE BOARD MEETING HELD ON 30.01.2010
The Board of Directors in its meeting held on 30.01.2010 approved the Un–audited financial results f
Press Release

9th January 2010
Outcome of the Extra-ordinary General Meeting held on 09.01.2010
The members of the Company in its Extra-ordinary General Meeting held on January 9, 2010 at the Regi

17th December 2009
STATE LEVEL ENERGY CONSERVATION AWARD
IOL Chemicals and Pharmaceuticals Limited has been awarded the 2nd prize State Level Energy Conserva
Press Release

15th December 2009
NATIONAL ENERGY CONSERVATION AWARD 2009
IOL Chemicals and Pharmaceuticals Limited has begged two most prestigious National Energy Conservati
Press Release

10th December 2009
Outcome of the Board Meeting held on 10.12.2009
The Board of Directors in its meeting held on 10.12.2009 has approved the following matters: 1. Inc

10th December 2009
IOLCP commences manufacturing of Iso Butyl Benzene at its new plant
The company has commenced the manufacturing operations at its new plant of Isobutyl Benzene (IBB) ha
Press Release

10th December 2009
CONVENING OF EXTRA-ORDINARY GENERAL MEETING ON 09TH JANUARY, 2010
The Extra-ordinary General Meeting of the Members of the Company will be held on Saturday, the 09th

31st October 2009
Outcome of the Board Meeting held on 31.10.2009
The Board of Directors in its meeting held on 31.10.2009 approved the Un–audited financial results f

18th August 2009
CONVENING OF ANNUAL GENERAL MEETING ON 12TH SEPTEMBER, 2009
The Twenty-second Annual General Meeting of the Members of the Company will be held on Saturday, the

30th June 2009
Outcome of the Board Meeting held on 30.06.2009
The Board of Directors in its meeting held on 30th June, 2009 approved the Annual accounts for the y

28th May 2009
Company has commenced the manufacturing operations
Company has commenced the manufacturing operations of Mono-chloro Acetic Acid (MCA) with the capacit

28th May 2009
IOL Chemicals & Pharmaceuticals all set to emerge as Indias largest Ibuprofen manufacturer
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has commenced the manufacturing operations of Mono

12th May 2009
IOLCP gets Star Export House status from Ministry of Commerce and Industry
Company has been accorded the coveted status of Star Export House in accordance with the provisions

5th May 2009
Punjab State Safety Award 2008 (First Prize in Chemical Sector)
Company has received Punjab State Safety Award 2008 (First Prize in Chemical Sector) for Largest Red

27th April 2009
FY 09 results by Jun 30, 2009
Company will publish its Audited Financial Results for the quarter / financial year ended March 31,

21st April 2009
Outcome of Allotment Committee Meeting 21.04.2009
Allotment Committee of the Board of Directors in its meeting held on April 21, 2009, has allotted 30

9th April 2009
Credit Ratings
Credit Analysis and Research Ltd (CARE) with reference to the exiting bank facilities of the Company

4th March 2009
Change in Directorate
IDBI Bank Ltd vide its letter dated February 16, 2009 has appointed Sh. Parminder Singh Cheema on th

20th February 2009
Outcome of Allotment Committee Meeting 20.02.2009
Allotment Committee of the Board of Directors in its meeting held on February 20, 2009, has allotted

12th February 2009
Coveted certifications for exports of its pharma product, Ibuprofen
Company has received coveted certifications for exports of its pharma product, Ibuprofen, to various

15th December 2008
National Energy Conservation Award 2008
IOL Chemicals and Pharmaceuticals Limited (IOLCP), has once again been awarded the most prestigious

12th December 2008
Accreditation Certificate Yoichi Masuzoe, Japan
The Company has received accreditation certificate of foreign drug manufacture from the Ministry of

31st October 2008
Outcome of the Board Meeting

The Board of Directors in its meeting held on 31.10.2008 has approved the followi

30th October 2008
Outcome of the Allotment Committee of the Board held on 30.10.2008
The Allotment Committee of the Board of Directors in its meeting held on 30.10.2008 allotted 24,30,5

20th September 2008
Outcome of the 21st Annual General Meeting held on 20.09.2008

The members of the Company in its Annual General Meeting held on 20th September, 2008 at the Reg

6th September 2008
Outcome of the Share Allotment Committee of the Board held on 06.09.2008
The Allotment Committee of the Board of Directors in its meeting held on 06.09.2008 allotted 18,85,5

27th August 2008
CONVENING OF ANNUAL GENERAL MEETING ON 20TH SEPTEMBER, 2008
Twenty-first Annual General Meeting of the Members of the Company will be held on Saturday, the 20th

31st July 2008
Outcome of the Board Meeting
The Board of Directors in its meeting held on 31st July, 2008 approved the following matters:
1.

5th May 2008
Outcome of the Board Meeting
The Board of Directors in its meeting held on today that is 5th May, 2008 approved the following matters :
5th May 2008
Combined Code of Corporate Governance and Conduct
Due to change in the clause 49 of Listing Agreement and present condition it is require to modify t

4th February 2008
IOL Chemicals posts 39 pc rise in profits
Press Release

15th December 2007
NATIONAL ENERGY CONSERVATION AWARD 2007- conferred to IOL Chemicals & Pharmaceuticals Limited
Press Release

1st December 2007
IOL shifts focus from chemicals to pharma
Press Release

20th November 2007
IOL CHEMICALS SET TO ENTER EUROPE Set Aside Rs 200 Cr. For Expansion
Press Release

22nd October 2007
Outcome of the Extra-ordinary General Meeting held on 22.10.2007
The members of the Company in its Extra-ordinary General Meeting held on 22.10.2007 approve

22nd October 2007
Outcome of the Share Allotment Committee of the Board held on 22.10.2007
The following securities has been allotted to persons mentioned below by

15th October 2007
Outcome of the Board Meeting held on 15.10.2007
The Board of Directors in its meeting held on 15.10.2007

25th September 2007
Outcome of the Board Meeting held on 25.09.2007
The Board of Directors in its meeting held on 25th September , 2007 has reviewed the completion of existing capacities which are as follows :

25th September 2007
Convening of Extra-ordinary General Meeting on 22.10.2007
The Extra-ordinary General Meeting of the Company to be held on Monday, the 22nd day of October, 2007 at 10.00 AM a

22nd September 2007
Outcome of the Annual General Meeting held on 22.09.2007
The Members in its meeting held on 22.09.2007 has approved the following matters:

28th August 2007
CONVENING OF ANNUAL GENERAL MEETING ON 22ND SEPT 2007
The Annual General Meeting of the Company will be held on Saturday ,the 22nd day of September 2007

21st August 2007
Outcome of the Share Allotment Committee of the Board held on 21.08.2007
The Share Allotment Committee of the Board in its meeting held on 21.08.2007 h

10th July 2007
Updates
The Company has completed the expansion of its Ibuprofen plant

23rd June 2007
Convening of Extra- Ordinary General Meeting on 23-07-2007
The Extra-ordinary General Meeting of the Company will be held on Monday, 23rd day of July, 2007 at 10.00

23rd June 2007
Outcome of the Board Meeting held on 23.06.2007
The Board of Directors in its meeting held on 23.06.2007 has approved the following matters:

10th February 2007
Trident Quality Pioneer Award won by Industrial Organics Ltd.
Industrial Organics Limited has won "Trident Quality Pioneer Award" under the medium-scale business category for Excellence in Quality at the '6th North-West QualTech Convention & Awards 2006'

14th December 2006
IOL Chemicals and Pharmaceuticals Ltd. has been awarded
IOL Chemicals and Pharmaceuticals Limited has been awarded the ‘National Energy Conservation Award-20

5th December 2006
Change of the Name of The Company
The name of the company has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Limited

12th February 2019
OUTCOME OF THE BOARD MEETING HELD ON 12 FEBRUARY 2019

Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on 12 February 2019 has approved the following:

1. Un-audited Financial Results for the Quarter and nine months ended 31 December 2018.

2. Appointment of Mr Rajender Mohan Malla, Independent Director as Chairman of the Board.

3. Re-appointment of Mr Vijay Garg, as Joint Managing Director of the company.

4. Modifications in the Code of Conduct to Regulate, Monitor and Report Trading by Insiders which will take effect from 1 April 2019.

5. Issue of 25,00,000 (Twenty five lakh) convertible warrants on preferential basis to M/s Towel Enterprises Limited, Promoter company at a price of ₹ 205/- per warrant being the price not less than the price determined in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, carrying an option to the holder of such warrants to subscribe to one equity share of ₹ 10/- for every warrant held, within 18 months from the date of allotment of the warrants.

6. Reclassification of the Authorised Share Capital of the Company from ₹ 80,00,00,000/- (Rupees eighty crore) divided into 2,20,00,000 (Two crore twenty lakh) Preference Shares of ₹ 10/- (Rupees ten) each and 5,80,00,000 (Five crore eighty lakh) Equity Shares of ₹ 10/- (Rupees ten) each to ₹ 80,00,00,000/- (Rupees eighty crore) divided into 8,00,00,000 (Eight crore) Equity Shares of ₹ 10/- (Rupees ten) each.

7. Convening of Extra-ordinary General Meeting of the shareholders on Wednesday, 13 March 2019 at 11:00 a.m. at registered office situated at Trident Complex, Raikot Road, Barnala, Punjab.

The details as required under the SEBI LODR read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 with respect to the proposed preferential issue are given in Annexure A.

The meeting of Board of Directors commenced at 12:00 NOON and concluded at 3:40 PM

Sr. No.	Particulars	Detail
1	Type of securities proposed to be issued (viz. equity shares, convertibles etc.)	Convertible Warrants
2	Type of issuance (further public offering, rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.)	Preferential allotment under Chapter V ICDR Regulations
3	Total number of securities proposed to be issued or the total amount for which the securities will be issued (approximately)	25,00,000 (Twenty five lakh) Warrants at a price ₹ 205/- per warrants to promoters
4	In case of preferential issue the listed entity shall disclose the following additional details to the stock exchange(s): i. Names of the investors ii. Post allotment of securities - outcome of the subscription, issue price / allotted price (in case of convertibles), number of investors iii. In case of convertibles - intimation on conversion of securities or on lapse of the tenure of the instrument	M/s Towel Enterprises Limited, Promoter Company (a) Issue price of each Warrant: ₹ 205/-. 25% (twenty five per cent) of the issue price of each Warrant will be paid upfront for allotment of the Warrant. The remaining 75% (seventy five per cent) of the issue price of each Warrant shall be payable at the time of conversion of the said Warrant into equity share of the Company. (b) Conversion ratio of each Warrant: 1 : 1 (c) Each Warrant can be converted into 1 (one) equity share of the Company at any time within 18 (eighteen) months from the date of allotment of Warrants. Will be intimated at the time of conversion.

14th November 2018
OUTCOME OF THE BOARD MEETING HELD ON 14 NOVEMBER 2018

Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on 14 November 2018 has approved the following:

• Appointment of Mr Varinder Gupta, Managing Director as Chairman of the company.
• The Board condoled untimely and sad demise of Dr M A Zahir, Chairman of the Company. The Board had conveyed its heartfelt condolences to the bereaved family on behalf of the company. The Board placed on record his invaluable contribution to the progress of the company.
• Un-audited Financial Results for the Quarter and half year ended 30 September 2018.
• Enhancement of existing manufacturing facilities of Metformin (Unit IV) from 3,000 MT per annum to 4,000 MT per annum in Pharma segment. The additional manufacturing facility of Metformin has been installed with capex of 2.71 crore. The project cost has been funded through internal accruals.
• Completion of Unit V to manufacture Clopidogrel Bisulphate and Fenofibrate with capacity of 180 MT per annum with capex of 19.26 crore. The project cost has been funded through internal accruals.
• Confirmed resolution passed by circulation confirming the reconstitution of Audit and Risk Management Committee consisting of Dr Sandhya Mehta, Independent Director as Chairman, Mr Chandra Mohan, Independent Director and Mr Vikas Gupta, Executive Director.
• Approved the Corporate Social Responsibility Policy, a copy of which will be placed on website of the company.

The meeting of Board of Directors commenced at 12:00 noon and concluded at 3.40 p.m.

11th August 2018
OUTCOME OF THE BOARD MEETING

Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you the Board of Directors in its meeting held on 16 May 2018 has approved:

• Un-audited Financial Results for the Quarter ended 30 June 2018.
  
  
• Appointment of M/s Ashwani & Associates (Firm registration no. 000497N), Chartered Accountants, Ludhiana, as Statutory Auditors of the Company on the recommendation of Audit and Risk Management Committee.
  
  Pursuant to the Section 139 and other applicable provisions as may be applicable of Companies Act, 2013, M/s SCV & Co. LLP, existing Statutory Auditors of the Company will retire as Statutory Auditors at the conclusion of the ensuing 31st Annual General Meeting of the Company.
  
  M/s Ashwani & Associates (Firm registration no. 000497N), Chartered Accountants, Ludhiana, appointed as the Statutory Auditors of the Company for a period of five years at the conclusion of the ensuing 31st Annual General Meeting, subject to the approval of the members.
  
  M/s Ashwani & Associates, Chartered Accountants, was established in 1978 having head office at Ludhiana with three branches in India and have nine partners. The firm has rich experience of 40 years in providing multidisciplinary services in areas such as Audit & Assurance, Tax and Management Consultancy to various Indian and Foreign Corporations. M/s Ashwani & Associates is an independent member of Geneva Group International (GGI). GGI is a global network of professional, independent accounting, consulting and law firms.
  
  
• Date for the 31st Annual General Meeting of the Company on Saturday, 29 September 2018 at 11 AM the registered office of the Company at Trident Complex, Raikot Road, Barnala.

Kindly note that the meeting of Board of Directors commenced at 12:00 noon and concluded at 04:35 p.m.

31st July 2018
NOTICE OF THE BOARD MEETING

the meeting of the Board of Directors is scheduled to be held on Saturday, the 11 August 2018 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 30 June 2018. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 01 August 2018 and will open after 48 hours, the financial results for the quarter ended 30 June 2018 made public.

7th May 2018
NOTICE OF THE BOARD MEETING

The meeting of the Board of Directors is scheduled to be held on Wednesday, the 16 May 2018 inter-alia to consider and approve the audited financial results of the Company for the quarter and year ended 31 March 2018. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 08 May 2018 and will open after 48 hours, the financial results for the quarter and year ended 31 March 2018 made public

3rd February 2018
03 FEBRUARY 2018 NOTICE OF BOARD MEETING

The meeting of the Board of Directors is scheduled to be held on Monday, the 12 February 2018 inter-alia to consider and approve the un-audited financial results of the Company for the quarter and nine months ended 31 December 2017. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 04 February 2018 and will open after 48 hours, the financial results for the quarter and nine months ended 31 December 2017 made public.

6th November 2017
NOTICE OF BOARD MEETING

The meeting of the Board of Directors is scheduled to be held on Monday, the 13th day of November, 2017 inter-alia to consider and approve the un-audited financial results of the Company for the quarter and half year ended 30 September 2017. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 07 November 2017 and will open after 48 hours, the financial results for the quarter and half year ended 30 September 2017 made public.

28th September 2017
PROCEEDINGS OF THE 30TH ANNUAL GENERAL MEETING OF THE COMPANY HELD ON 28 SEPTEMBER 2017

The 30th Annual General Meeting of the Company was held on Thursday, 28 September 2017 at 11:00 AM – 12:15 PM at the Registered Office of the Company: Trident Complex, Raikot Road, Barnala-148101. In accordance with the provisions of Article 98 of Articles of Association of the Company, Dr M A Zahir, Chairman of the Board took the Chair of the meeting. The Chairman welcomed the members and declared that the quorum was present and called the meeting to order and conducted the proceedings of the meeting. The Chairman briefed the members on the performance and future plans of the Company. A copy of the Chairman’s speech was also circulated to the members present in the meeting. The company had provided a facility to the Members to vote electronically (“remote e-voting”) from 24 September 2017 to 27 September 2017. The Company has also arranged venue e-voting for the members present in the meeting who could not exercise their voting through remote e-voting. The following item of business as set out in the Notice convening the AGM were put for members approval: 1. Adoption of the audited financial statements of the Company for the financial year ended 31 March 2017 and the reports of the Board of Directors and Auditors thereon. 2. Re-appointment of Mr Vijay Garg (holding DIN 06510248) as director of the Company, who retires by rotation and being eligible offered himself for re-appointment. 3. Re-appointment of Mr Vikas Gupta (holding DIN 07198109) as director of the Company, who retires by rotation and being eligible offered himself for re-appointment. 4. Ratify the appointment of M/s S C Vasudeva & Co., Chartered Accountants, New Delhi, as statutory auditor of the Company to hold office till the conclusion of thirty first annual general meeting of the Company on such remuneration as may be fixed by the Board of Directors of the Company. 5. Increase the remuneration of Mr Varinder Gupta, Managing Director of the Company consisting of basic salary of Rupees eight lakh per month and other allowances as given in the notice with effect from 1 April 2017 for remaining period of his tenure that is upto 31 August 2018. 6. Increase of the gross remuneration of Mr Vijay Garg, Joint Managing Director of the Company consisting of basic salary of Rupees five lakh eighty thousand per month and other allowances as given in the notice with effect from 01 April 2017 for remaining period of his tenure that is upto 01 March 2019. 7. Increase of the gross remuneration of Mr Vikas Gupta, Executive Director of the Company consisting of basic salary of Rupees two lakh per month and other allowances as given in the notice with effect from 01 April 2017 for remaining period of his tenure that is upto 28 May 2020. 8. Increase of the gross remuneration of Mr Vijay Singla, Director ( Works) of the Company consisting of basic salary of Rupees two lakh sixty thousand per month and other allowances as given in the notice with effect from 01 April 2017 upto 27 May 2017. 9. Approval of the remuneration of Rupees one lakh twenty thousand plus GST and out of pocket expenses to M/s Ramanath Iyer & Co., Cost Accountants, New Delhi, cost auditor for the financial year ending 31 March 2018. The Chairman informed the members that Mr Vinay Kohli, partner K K Kapoor and Associates, Chartered Accountants, was appointed as scrutinizer to conduct the remote e-voting and venue e-voting. The result of evoting shall be disseminated to the Stock Exchanges and will also be displayed on the website of CDSL and Company’s website at www.iolcp.com. Thereafter, Chairman thanked the members and others for attending the Annual General Meeting of the Company. The Scrutinizer submitted his report on 28 September 2017. As per Scrutinizer’s report all the resolutions set out in the notice calling the meeting have been passed with requisite majority and are deemed to be passed on the date of Annual General Meeting i.e. 28 September 2017.

1st September 2017
NOTICE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE

Dear Sir, This is to inform you that 30th Annual General Meeting of the Company is scheduled to be held on Thursday, 28 September 2017 at 11:00 A.M. at the Registered office: Trident Complex, Raikot Road, Barnala, Punjab. Pursuant to Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of notice of Annual General Meeting for your reference and record. Further pursuant to the Regulation 42 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby intimated that the Register of Members and Share Transfer Books remain closed on Thursday, 21 September 2017 for the purpose of Annual General Meeting of the Company. Further pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have provided the facility of remote e-voting to the members, who are holding shares as on the cut-off date (record date) i.e. 21 September 2017. The remote e-voting will commence on 24 September 2017 at 9:00 AM and ends on 27 September 2017 at 5:00 PM.

10th August 2017
NOTICE OF THE BOARD MEETING

This is to inform you that the meeting of the Board of Directors is scheduled to be held on Friday, the 18th day of August, 2017 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 30 June 2017.Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 11 August 2017 and will open after 48 hours, the financial results for the quarter ended 30 June 2017 made public.

20th May 2017
NOTICE OF THE BOARD MEETING

This is to inform you that the meeting of the Board of Directors is scheduled to be held on Saturday, the 27th day of May, 2017 inter-alia to consider and approve the audited financial results of the Company for the quarter and year ended 31 March 2017. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 21 May 2017 and will open after 48 hours, the financial results for the quarter and the year ended 31 March 2017 made public.

12th April 2017
EUGMP CERTIFICATION FROM NATIONAL INSTITUTE OF PHARMACY AND NUTRITION, HUNGARY

The company has received EUGMP Certification from National Institute of Pharmacy and Nutrition, Hungary, for its product Ibuprofen, Lamotrigine, Metformin Hydrochloride confirming compliance with principals of Good Manufacturing Practices as provided by European Union Legislation. This will facilitate the company to expand its product portfolio in the European Market.

11th February 2017
OUTCOME OF THE MEETING OF INDEPENDENT DIRECTORS HELD ON 11 FEBRUARY 2017

The Independent Directors in their meeting held on today i.e. 11 February 2017 inter-alia reviewed the performance of non-independent directors and the Board as a whole; reviewed the performance of the Chairman of the company and assessed the quality, quantity and timeliness of flow of information between the company management and the Board in line with the requirements of Regulation 25 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 read with applicable provisions of Schedule IV of the Companies Act, 2013

31st January 2017
NOTICE OF THE BOARD MEETING

This is to inform you that the meeting of the Board of Directors is scheduled to be held on Saturday, the 11th day of February, 2017 inter-alia to consider and approve the un-audited financial results of the Company for the quarter and nine months ended 31 December 2016. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 01 February 2017 and will open after 48 hours, the financial results for the quarter ended 31 December 2016 made public.​

4th January 2017
CREDIT RATING

Pursuant to Regulation 30 and any other provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Credit Analysis & Research Ltd (CARE) has revised the credit rating for Long term Bank Facilities to 'CARE BB; Stable' (Double B; Outlook: Stable) from 'CARE BB-' (Double B Minus) and reaffirmed the credit rating for Short term Bank Facilities to 'CARE A4' (A Four).

15th December 2016
NATIONAL ENERGY CONSERVATION AWARD - 2016

The Company has won the National Energy Conservation Award - 2016. The company has awarded with the Second prize in Chemical Sector for its continued efforts towards new technology implementation so as to conserve energy resources of the country. Mr Vijay Singla, Director (Works) received the award from Sh. Pyush Goyal - The Hon'ble Minister of State (I/C) for Power, Coal, New & Renewable Energy and Mines at a National Energy Conservation Award function held on 14 December 2016, National Energy Conservation Day, at New Delhi.

29th October 2016
NOTICE OF THE BOARD MEETING

This is to inform you that the meeting of the Board of Directors is scheduled to be held on Monday, the 07th day of November, 2016 inter-alia to consider and approve the un-audited financial results of the Company for the quarter and half year ended 30 September 2016. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 30 October 2016 and will open after 48 hours, the financial results for the quarter ended 30 September 2016 made public. ​

30th July 2016
NOTICE OF BOARD MEETING

The meeting of the Board of Directors is scheduled to be held on Monday, the 08th day of August, 2016 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 30 June 2016. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 31 July 2016 and will open after 48 hours, the financial results for the quarter ended 30 June 2016 made public.

14th May 2016
OUTCOME OF THE BOARD MEETING HELD ON 14 MAY 2016

This is to inform you that Mr Yogesh Goel, Independent Director and Mr Ravi Pratap Singh, Independent Director, have tendered resignations from the directorship of the company which were accepted by the Board of Directors in its meeting held today i.e. 14 May 2016. The Board appreciated the services rendered by them during their tenure as directors of the company.​

29th March 2016
OUTCOME OF THE MEETING OF INDEPENDENT DIRECTORS HELD ON 29 MARCH 2016

The Independent Directors in their meeting held on today i.e. ​29 March 2016 inter-alia reviewed the performance of non-independent directors and the Board as a whole; reviewed the performance of the Chairman of the company and assessed the quality, quantity and timeliness of flow of information between the company management and the Board in line with the requirement of regulation 25 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 read with applicable provisions of Schedule IV of the Companies Act, 2013. This is for your information please.

3rd March 2016
CREDIT RATING

Pursuant to Regulation 83(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Credit Analysis & Research Ltd (CARE) has reaffirmed the following credit rating for long term and short term bank facilities of the company: Long term Bank Facilities : 'CARE BB-' (Double B Minus) Short term Bank Facilities : 'CARE A4' (A Four)

3rd March 2016
CERTIFICATES OF PHARMACEUTICALS PRODUCTS (COPP) CONFIRMING WHO GUIDELINES

The company has received "Certificates of Pharmaceuticals Products" (COPP) for manufacturing facilities of following products in its exiting Multiple Purpose Plant conforming to the WHO guidelines: (1) Ibuprofen IP/BP/USP/Ph.Eur./JP (2) Lamotrigine IP/BP/USP/Ph.Eur. from, Food & Drugs Administration, Punjab. This will facilitate the company to broaden its presence in export market. Ibuprofen is, a non-steroidal anti-inflammatory drug (NSAID), used for the treatment of various types of pains and Lamotrigine is, an anti-convulsant drug, used for the treatment of epileptic seizures . The company is already having US Food and Drug Administration (USFDA) and European Directorate for the Quality of Medicines & HealthCare (EDQM) approved Ibuprofen manufacturing facilities.

30th January 2016
OUTCOME OF THE BOARD MEETING HELD ON 30 JANUARY 2016

The Board of Directors in its meeting held on today i.e. 30 January 2016 has considered and approved the following matters: 1. Un-audited financial results for the quarter ended 31 December 2015. 2. Re-appointment of Mr Vijay Kumar Garg as Joint Managing Director of the Company for three year w.e.f. 02 March 2016. 3. Re-appointment of Mr Vijay Singla as Director(works) of the Company for three year w.e.f. 01 April 2016. 4. Enter into new uniform Listing Agreement with the BSE Limited and National Stock Exchange of India Limited as per Circular dated October 13, 2015 issued by the Securities and Exchange Board of India (SEBI). 5. In compliance with Requlation 30(5) of the SEBI(Listing Obligation and Disclosure Requirements) Regulations,2015, the Contact details of the Key Managerial Personnel(KMP) authorized for the purpose of determining materiality of particular event/information are as follows: Name of the KMP Designation Contract Details Mr Varinder Gupta Managing Director varindergupta@iolcp.com 0161-2225531 Mr Vijay Kumar Garg Joint Managing Director vijaygarg@iolcp.com 0161-2225531 Mr Krishan Singla Vice President & Company Secretary krishan@iolcp.com 0161-2225531

18th December 2015
CHANGE IN ADDRESS OF REGISTRAR AND SHARE TRANSFER AGENT(RTA)

The Company Registrar and Share Transfer Agent "M/s Alankit Assignments Limited" has communicated regarding their new contact details as under: Registered Office : Alankit Assignments Limited 205 - 208, Anarkali Complex, Jhandewalan Extension, New Delhi - 110055 Corporate Office : Alankit Assignments Limited "Alankit Heights", 1E/13, Jhandewalan Extension, New Delhi - 110055 Telephones: +91-11-23541234, 42541234 Fax: +91-11- 41543474

30th November 2015
OUTCOME OF ALLOTMENT COMMITTEE​ MEETING

The Allotment Committee of the Board of Directors in its meeting held on 30 November 2015 has allotted 4,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. On the allotment of these shares all the warrants stands converted as on date. Consequent upon the issue of the above 4,00,000 equity shares, the total paid-up capital of the company stands increased to 5,62,05,502 fully paid equity shares of 10/- each.

27th November 2015
OUTCOME OF ALLOTMENT COMMITTEE MEETING

The Allotment Committee of the Board of Directors in its meeting held on 27 November 2015 has allotted 7,25,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 7,25,000 equity shares, the total paid-up capital of the company stands increased to 5,58,05,502 fully paid equity shares of 10/- each.

24th November 2015
OUTCOME OF THE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 24 NOVEMBER 2015

The Allotment Committee of the Board of Directors in its meeting held on 24 November 2015 has allotted 5,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 5,00,000 equity shares, the total paid-up capital of the company stands increased to 5,50,80,502 fully paid equity shares of 10/- each.

30th October 2015
OUTCOME OF THE BOARD MEETING HELD ON 30 OCTOBER 2015

The Board of Directors in its meeting held on today i.e. 30 October 2015 has approved the ​Un-audited financial results for the quarter/ half year ended 30 September 2015.

29th October 2015
OUTCOME OF THE ALLOTMENT COMMITTEE

The Allotment Committee of the Board of Directors in its meeting held on 29 October 2015 has allotted 8,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 8,00,000 equity shares, the total paid-up capital of the company stands increased to 5,45,80,502 fully paid equity shares of 10/- each.

21st October 2015
OUTCOME OF THE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 21 OCTOBER 2015

The Allotment Committee of the Board of Directors in its meeting held on 21 October 2015 has allotted 6,75,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 6,75,000 equity shares, the total paid-up capital of the company stands increased to 5,37,80,502 fully paid equity shares of 10/- each.

21st October 2015
NOTICE OF THE BOARD MEETING

This is to inform you that the meeting of the Board of Directors convened to be held on Saturday,31 October, 2015 has been re-scheduled to be held on Friday, 30 October, 2015 inter-alia to consider the un-audited financial results of the Company for the quarter/ half year ended 30 September 2015.

9th October 2015
OUTCOME OF ALLOTMENT COMMITTEE

The Allotment Committee of the Board of Directors in its meeting held on 09 October 2015 has allotted 5,50,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 5,50,000 equity shares, the total paid-up capital of the company stands increased to 5,31,05,502 fully paid equity shares of 10/- each.

25th August 2015
OUTCOME OF ALLOTMENT COMMITTEE

This is to inform you that the Allotment Committee of the Board of Directors in its meeting held on 25 August 2015 has allotted 6,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 6,00,000 equity shares, the total paid-up capital of the company stands increased to 5,25,55,502 fully paid equity shares of 10/- each.

20th August 2015
OUTCOME OF ALLOTMENT COMMITTEE

This is to inform you that the Allotment Committee of the Board of Directors in its meeting held on 20 August 2015 has allotted 5,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 5,00,000 equity shares, the total paid-up capital of the company stands increased to 5,19,55,502 fully paid equity shares of 10/- each.​

18th August 2015
OUTCOME OF ALLOTMENT COMMITTEE

The Allotment Committee of the Board of Directors in its meeting held on 18 August 2015 has allotted 5,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 5,00,000 equity shares, the total paid-up capital of the company stands increased to 5,14,55,502 fully paid equity shares of 10/- each. This is for your information and record please.​

13th August 2015
OUTCOME OF THE BOARD MEETING HELD ON 13 AUGUST 2015

The Board of Directors in its meeting held on today i.e. 13 August 2015 has considered and approved the following matters: 1. ​ Un-audited financial results for the quarter ended 30 June 2015. 2. Appointment of Mr Pardeep Khanna as Chief Financial Officer (CFO) of the Company in place of Mr Rakesh Mahajan. The company is enhancing the role of Mr Rakesh Mahajan with higher responsibilities.

4th August 2015
NOTICE OF BOARD MEETING AND CLOSE THE TRADING WINDOW

The meeting of the Board of Directors is scheduled to be held on Thursday, the 13th day of August, 2015 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 30 June 2015. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 05 August 2015 and will open after 48 hours, the financial results for the quarter ended 30 June 2015 made public.

3rd July 2015
OUTCOME OF THE ALLOTMENT COMMITTEE MEETING

The Allotment Committee of the Board of Directors in its meeting held on 03 July 2015 has allotted 5,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 5,00,000 equity shares, the total paid-up capital of the company stands increased to 5,04,55,502 fully paid equity shares of 10/- each.

1st July 2015
RENEWAL OF "HALAL CERTIFICATE" FOR THE YEAR 2015-16

The Company has got renewal of "HALAL CERTIFICATE" from Halal Committee, Jamiat Ulama - E - Maharashtra for Ibuprofen, Iso Butyl Benezene, Ethyl Acetate and other products of the company for the year 2015-2016. It will facilitate the company to explore the untapped export markets for its products.

29th June 2015
OUTCOME OF THE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 29 JUNE 2015

The Allotment Committee of the Board of Directors in its meeting held on 29 June 2015 has allotted 8,00,000 equity shares​ of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 8,00,000 equity shares, the total paid-up capital of the company stands increased to 4,99,55,502 fully paid equity shares of 10/- each.

10th June 2015
OUTCOME OF THE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 10 JUNE 2015

The Allotment Committee of the Board of Directors in its meeting held on 10 June 2015 has allotted 5,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 5,00,000 equity shares, the total paid-up capital of the company stands increased to 4,91,55,502 fully paid equity shares of 10/- each.

29th May 2015
OUTCOME OF BOARD MEETING 29 MAY 2015

The Board of Directors in its meeting held on today i.e. 29 May 2015 has considered and approved the following matters: 1. Financial accounts for the quarter and the financial year ended 31 March 2015. 2. Appointment of Mr Vikas Gupta as Additional and Executive Director of the Company w.e.f. 29 May 2015 3. Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information under Regulation (8) of SEBI (Prohibition of Insider Trading) Regulations, 2015 4. Code of Conduct to Regulate, Monitor and Report Trading by Insiders under Regulation (9) of SEBI (Prohibition of Insider Trading) Regulations, 2015

27th May 2015
OUTCOME OF THE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 27 MAY 2015

The Allotment Committee of the Board of Directors in its meeting held on 27 May 2015 has allotted 5,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 5,00,000 equity shares, the total paid-up capital of the company stands increased to 4,86,55,502 fully paid equity shares of 10/- each.

12th May 2015
OUTCOME OF ALLOTMENT COMMITTEE MEETING

The Allotment Committee of the Board of Directors in its meeting held on 12 May 2015 has allotted 5,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval. Consequent upon the issue of the above 5,00,000 equity shares, the total paid-up capital of the company stands increased to 4,81,55,502 fully paid equity shares of 10/- each.

5th May 2015
CEP CERTIFICATION FOR PRODUCT METFORMIN HYDROCHLORIDE BY EDQM

The company has been awarded with CEP certification (Certificates of Suitability) dated April 17, 2015 for its product Metformin Hydrochloride by European Directorate for the Quality of Medicines & HealthCare (EDQM) authorities, Council of Europe, France. The certificate is valid for a period of five years from the date of issue. Now, the Company is able to sell Metformin Hydrochloride in Europe resulting into increase in higher value added export turnover and margin. The Company has already holding valid CEP certification (Certificates of Suitability) for its products Ibuprofen & Lamotrigine from European Directorate for the Quality of Medicines & HealthCare (EDQM) authorities, Council of Europe, France and selling these products in Europe.

1st April 2015
DISCLOSURE OF TRADING WINDOW CLOSED

As per the Company's Code of Conduct for Prohibition of Insider Trading framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the quarter/ year ended 31 March 2015 for all the Designated Employees (including Directors) of the Company from 01 April 2015 upto 48 hours of the conclusion of the Board Meeting in which the financial results for the quarter/ year ended 31 March 2015 are to be considered and approved. Accordingly all the Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of Trading Window.

30th March 2015
OUTCOME OF THE MEETING OF INDEPENDENT DIRECTORS

The Independent Directors in their meeting held on today i.e. 30 March 2015 inter-alia evaluated the performance of non-independent directors and the Board as a whole; evaluated the performance of the Chairman of the company and assessed the quality, quantity and timeliness of flow of information between the company management and the Board in line with the requirement of Clause 49 of the Listing Agreement read with applicable provisions of Schedule IV of the Companies Act, 2013.

13th February 2015
OUTCOME OF BOARD MEETING

The Board of Directors in its meeting held on today i.e. 13 February 2015 has approved the Un-audited financial results for the quarter and nine month ended 31 December 2014.​

6th February 2015
06 FEBRUARY 2015 CLARIFICATION

This has reference to the mail received 06 February 2015 from ET NOW regarding the rumour about the company of making default on debt obligations with Punjab National Bank. In this regard the company have clarified to ET NOW that the account with Punjab National Bank is standard. This clarification is provided in the interest of the investors.

5th February 2015
NOTICE OF THE BOARD MEETING

The meeting of the Board of Directors is scheduled to be held on Friday, the 13th day of February, 2015 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 31 December 2014

28th November 2014
OUTCOME OF THE BOARD MEETING 28 NOVEMBER 2014

The Board of Directors in its meeting held on today i.e. 28 November 2014 has considered and approved the following matters: 1. Un-audited financial results for the quarter/half year ended 30 September 2014 2. Allotment of 50,51,924 equity shares of face value of 10/- each on conversion of US$ six million Zero Coupon Unsecured Foreign Currency Convertible Bonds issued in May 2010 to the bondholders and allotment of 8,41,987 equity shares of the face value 10/- each on conversion of US $ one million bonds in the name of custodian on behalf of the bondholders, who have not submitted their conversion notices for mandatory conversion. The paid up capital of the company increased from 4,17,61,591 equity shares of 10/- each to 4,76,55,502 equity shares of 10/- each on the allotment aforesaid shares. 3. Constituted a Committee with M/s KPMG as its advisors, to unleash the potential of the company through the various options of joint ventures, restructuring of business etc.

21st November 2014
DENY NEWS ARTICLE THAT APPEARED IN ECONOMIC TIMES

We refer to the news article that appeared today i.e. 21.11.2014 in a leading business daily Economic Times, regarding "IOL Chem's JV with a foreign ally to catalyst growth". We hereby deny any such developments and the report is speculative in nature.

18th November 2014
NOTICE OF THE BOARD MEETING 18 NOVEMBER 2014

The meeting of the Board of Directors is scheduled to be held on Friday, the 28th day of November, 2014 inter-alia to consider and approve the Conversion of FCCBs into equity shares, un-audited financial results of the Company for the quarter and half year ended 30 September 2014 and to constitute a Committee to consider joint venture(s), restructuring etc to unleash the potential of the Company.​

18th November 2014
OUTCOME OF THE ALLOTMENT COMMITTEE 18 NOVEMBER 2014

The Allotment Committee of the Board of Directors in its meeting held on 18 November 2014 allotted 7,50,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014. Consequent upon the issue of the above 7,50,000 equity shares, the total paid-up capital of the company stands increased to 4,17,61,591 fully paid equity shares of 10/- each.

14th November 2014
OUTCOME OF THE ALLOTMENT COMMITTEE MEETING 14 NOVEMBER 2014

The Allotment Committee of the Board of Directors in its meeting held on 14 November 2014 allotted 10,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014. Consequent upon the issue of the above 10,00,000 equity shares, the total paid-up capital of the company stands increased to 4,10,11,591 fully paid equity shares of 10/- each.

13th November 2014
OUTCOME OF THE ALLOTMENT COMMITTEE MEETING 13 NOVEMBER 2014

The Allotment Committee of the Board of Directors in its meeting held on 13 November 2014 allotted 7,00,000 equity shares of 10/- each to M/s Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on 04 July 2014. Consequent upon the issue of the above 7,00,000 equity shares, the total paid-up capital of the company stands increased to 4,00,11,591 fully paid equity shares of 10/- each .

29th October 2014
OUTCOME OF THE BOARD MEETING HELD ON 29 OCTOBER 2014

The Board of Directors in its meeting held on today i.e. 29 October 2014 has considered and approved the following matters: 1. To exercise the CALL OPTION to convert all the outstanding US$ 7 million Zero Coupon Unsecured Convertible Bonds due June 2015 pursuant to the condition 6.1.2 of the terms and conditions of the Bonds (the "Conditions") held by the Bondholders on 28 November 2014 , as per particulars given below : S. No. Particulars Particulars 1. Bonds to be converted Principal amount of US$ 7 million Zero Coupon Unsecured Convertible Bonds due June 2015 2. Outstanding Amount US$ 7 million 3. Accredited value ​of Bonds to be converted Principal amount as on 28 November 2014 plus interest accrued thereon that is accredited value 1.3628974 times the principal amount ​4. Conversion date 28 November 2014 5. Conversion price 77 per share of face value of 10/- each 6. Exchange price of US$ 47.57 pre fixed per US$ 2. To incorporate a overseas subsidiary company to promote the business of the company

27th October 2014
NOTICE OF BOARD MEETING​

The meeting of the Board of Directors is scheduled to be held on Wednesday, the 29th day of October, 2014 inter-alia to consider to exercise CALL OPTION by the company to convert FCCBs into equity shares.

22nd August 2014
OUTCOME OF THE BOARD MEETING HELD ON 22 AUGUST 2014

The Board of Directors in its meeting held on today i.e. 22 August 2014 has approved the following: 1. The Board has approved the appointment of Dr Sandhya Mehta, as Additional and Independent Director w.e.f 22 August 2014. She has vast 22 experience to her credit. She has published seven books in addition to numerous papers published in reputed National & International Journals. She holds master degree in Business Management and Ph.D. 2. The twenty-seventh Annual General Meeting of the members of IOL Chemicals and Pharmaceuticals Limited will be held on Tuesday, 30 September 2013 at 11:00 AM at the Registered Office of the Company; Trident Complex, Raikot Road, Barnala, Punjab. 3. The Register of Members and share transfer books will remain closed from Tuesday, 23 September 2014 to Tuesday, 30 September 2014 (both days inclusive) for the purpose of Annual General Meeting of the Company.​

14th August 2014
OUTCOME OF BOARD MEETING HELD ON 14 AUGUST 2014

The Board of Directors in its meeting held on today i.e. 14 August 2014 has approved the Un-audited financial results for the quarter ended 30 June 2014 The net sales for the quarter ended 30 June 2014 is 121.19 crore against 140.05 crore during corresponding quarter ended 30 June 2014. The Profit before interest & depreciation has increased by 1.72% to 24.88 crore during the quarter under review against 24.46 crore during the corresponding quarter ended 30 June 2014 and Profit after tax 1.25 crore during the quarter ended 30 June 2014.

31st July 2014
NOTICE OF BOARD MEETING

This is to inform you that the meeting of the Board of Directors is scheduled to be held on Thursday, the 14th day of August, 2014 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 30 June 2014.​

4th July 2014
OUTCOME OF ALLOTMENT COMMITTEE HELD ON 04 JULY 2014 04 JULY 2014

The Share Allotment Committee of the Board of Directors in its meeting held on 04 July 2014 allotted: 11,50,000 equity shares of 10/- each at a premium of 18/- per share to the non promoters of the company which will be locked in for a period of one year from the date of trading approval. 1,10,00,000 (One crore ten lac) warrants to the non promoters, carrying an option to the holder of such warrants to subscribe to one equity share of 10/- at premium of 18/- per share for every warrant held, within 18 months from the date of allotment of the warrants. Consequent upon the issue of the above 11,50,000 equity shares, the total paid-up capital of the company stands increased to 39311591 fully paid equity shares of 10/- each.

21st June 2014
OUTCOME OF ALLOTMENT COMMITTEE HELD ON 21 JUNE 2014

The Share Allotment Committee of the Board of Directors in its meeting held on 21 June 2014 allotted: 22,00,000 equity shares of 10/- each at a premium of 18 per share to the non promoters of the company which will be locked in for a period of one year from the date of trading approval. 53,60,713 equity shares of face value of 10 each at a premium of 18 per share to promoter group companies which will be locked in for a period of three years from the date of trading approval and 17,85,714 equity shares of face value of 10 each at a premium of 18 per share to non promoter which will be locked in for a period of one year from the date of trading approval on the redemption of preference shares. Consequent upon the issue of the above 93,46,427 equity shares, the total paid-up capital of the company stands increased to 3,81,61,591 fully paid equity shares of 10/- each.

20th June 2014
OUTCOME OF THE EXTRA-ORDINARY GENERAL MEETING OF THE COMPANY

An Extraordinary General meeting of members was held today June 20,2014 at Barnala and following ordinary and special business have been approved by the members with requisite majority by e-voting and poll: 1) Increasing the Authorized Share capital of the Company from 54,00,00,000/- divided into 2,20,00,000 Preference shares of 10/- each and 3,20,00,000 Equity Shares of 10/- each to 80,00,00,000/- divided into 2,20,00,000 Preference Shares of 10/- each and 5,80,00,000 Equity Shares of 10/- each. 2) Amending Clause V of Memorandum of Association of the Company effecting increase in Authorised Share Capital of the Company 3) Redeem the 1,50,10,000 1% Non Cumulative Redeemable Preference Shares issued to the promoter group companies and 50,00,000, 7% Non Cumulative Redeemable reference Shares issued to non promoter company by issuing, offering and allotting equity shares of the company of face value of 10/- each at a premium of 18/- per share or at a price as determined in accordance with the SEBI (ICDR) Regulations which ever is higher 4) Issue 42,50,000 equity share of face value of 10/- each at a premium of 18/- per share or at price as determined in accordance with the SEBI (ICDR) Regulations which ever is higher and 1,10,00,000 warrants with an option to subscribe to an equity share of face value of 10 at a premium of 18/- per share or at a price as determined in accordance with the SEBI (ICDR) Regulations which ever is higher for each warrant to non promoters with in the period of eighteen months from the date of allotment of warrants.

30th May 2014
OUTCOME OF BOARD MEETING HELD ON 30 MAY 2014

The Board of Directors in its meeting held on today i.e. 30 May 2014 has considered and approved the following matters: 1. Audited accounts for the quarter and the financial year ended 31 March 2014. 2. Constituted ESOP Compensation Committee to formulate, administer and supervise the Employee Stock Option Scheme.

21st May 2014
OUTCOME OF BOARD MEETING HELD ON 21.05.2014

The Board of Directors in its meeting held on today i.e.21 May 2014 has approved the following 1. Increase in the Authorised Share Capital of the Company from 54 crores to 80 crores. 2. Issue of upto 50.00,000 equity shares of face value 10/- each and issue of upto 1,10,00,000 equity warrants, carrying an option to the holder of such warrants to subscribe to one equity share of face value of 10/- each for each warrant held within 18 months from the date of allotment of the warrants , on preferential basis, as per the SEBI ( ICDR ) Regulations to the Non-Promoters . 3. Preponing the redemption of 1,50,10,000,1% Non Cumulative Redeemable Preference Shares of face value of 10/- each issued to the promoter group companies and 50,00,000,7% Non Cumulative Redeemable Preference Shares of face value of 10/- each issued to non promoters by way of issue equity share of 10/- each as per the SEBI ( ICDR ) Regulations . 4. Convening of Extra-ordinary General Meeting on 20 June 2014

19th May 2014
NOTICE OF THE BOARD MEETING 21 MAY 2014

This is to inform you that the meeting of the Board of Directors is scheduled to be held on Wednesday, the 21 May, 2014 inter-alia to consider the preferential issue of shares / warrants to the promoters and non- promoters of the company

15th May 2014
NOTICE OF THE BOARD MEETING 30 MAY 2014

The meeting of the Board of Directors is scheduled to be held on Friday, the 30th day of May, 2014 inter-alia to consider and approve the audited financial results of the Company for the quarter and financial year ended 31 March 2014.

8th February 2014
OUTCOME OF THE BOARD MEETING HELD ON 08 FEBRUARY 2014

Board of Directors in its meeting held on today i.e. 08 February 2014 has approved the following: 1. Un-audited financial results for the quarter and nine months ended 31 December 2013 The net sales for the quarter ended 31 December 2013 is 138.78 crore against 117.05 crore during corresponding quarter ended 31 December 2012. The Profit before interest & depreciation has decreased by 1.25% to 23.63 crore during the quarter under review against 23.93 crore during the corresponding quarter ended 31 December 2012 and Profit after tax 0.59 crore during the quarter ended 31 December 2013. 2. Considered and approved the extension of date of redemption of 7% Non Cumulative Redeemable Preference Shares subject to the approval of the shareholders through Postal Ballot. 3. The Board considered and discussed to restructure the business of the company and authorized the Managing Director to explore the possibility of various options consisting of demerger or merger, incorporate one or more subsidiary companies, joint ventures and to transfer the business of one segment/product, or in combination or otherwise arrange the business of company to unleash the potential of the Company.

30th January 2014
NOTICE OF THE BOARD MEETING 08 FEBRUARY 2014

The meeting of the Board of Directors is scheduled to be held on Saturday, the 08th day of February, 2014 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 30 september 2013.

9th November 2013
OUTCOME OF THE BOARD MEETING HELD ON 09 NOVEMBER 2013

Board of Directors in its meeting held on today i.e. 09 November 2013 has approved the Un-audited financial results for the quarter/half year ended 30 September 2013 The net sales for the quarter ended 30 September 2013 is 154.94 crore against 104.20 crore during corresponding quarter ended 30 September 2012. The Profit before interest & depreciation has increased by 12.15% to 25.11 crore during the quarter under review against 22.39 crore during the corresponding quarter ended 30 September 2012 and Profit after tax 1.07 crore during the quarter ended 30 September 2013.

1st November 2013
NOTICE OF THE BOARD MEETING 09 NOVEMBER 2013

The meeting of the Board of Directors is scheduled to be held on Saturday, the 09th day of November, 2013 inter-alia to consider and approve the un-audited financial results of the Company for the quarter and half year ended 30 september 2013.

3rd September 2013
NOTICE OF 26TH ANNUAL GENERAL MEETING

Notice is hereby given that the Twenty-fifth Annual General Meeting of the Members of the Company will be held on Saturday, the 28th day of September, 2013 at 11.30 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which is posted to the Members separately at their registered addresses in India. Notice is also hereby given pursuant to Section 154 of the Companies Act, 1956 that the Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, the 24th day of September, 2012 to Saturday, the 28th day of September, 2012 (both days inclusive).

12th August 2013
OUTCOME OF THE BOARD MEETING HELD ON 12 AUGUST 2013

The Board of Directors in its meeting held on today i.e.12 August 2013 has approved the following:
1. Un-audited financial results for the quarter ended 30 June 2013 Total income for the quarter ended 30 June 2013 is 140.05 crore against 126.49 crore during corresponding quarter ended 30 June 2012. The Profit before interest & depreciation has increased by 5.16% to 24.45 crore during the quarter under review against 23.25 crore during the corresponding quarter ended 30 June 2012 and Profit after tax 0.82 crore during the quarter ended 30 June 2013.
2. The twenty-sixth Annual General Meeting of the members of IOL Chemicals and Pharmaceuticals Limited will be held on Saturday, 28 September 2013 at 11:30 AM at the Registered Office of the Company; Trident Complex, Raikot Road, Barnala, Punjab
3. The Register of Members and share transfer books will remain closed from Tuesday, 24 September 2013 to Saturday, 28 September 2013 (both days inclusive) for the purpose of Annual General Meeting of the Company.

3rd August 2013
NOTICE OF THE BOARD MEETING 03 AUGUST 2013

The meeting of the Board of Directors is scheduled to be held on Monday, the 12th day of August, 2013 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 30 June 2013.

27th May 2013
OUTCOME OF THE BOARD MEETING HELD ON 27 MAY 2013

The Board of Directors in its meeting held on today i.e. 27 May 2013 has considered and approved the following matters: 1.Audited accounts for the quarter and the financial year ended 31 March 2013. 2.Considered and approved the redesignation of Mr Vijay Kumar Garg as Joint Managing Director of the Company 3.Considered and approved the resignation of Mr Varinder Gupta  from Chairman of the Company 4.Considered and approved the appointment of Dr M A Zahir as Chairman of the Board of the Company

18th May 2013
NOTICE OF THE BOARD MEETING 18 MAY 2013

The meeting of the Board of Directors is scheduled to be held on Monday, the 27th day of May, 2013 inter-alia to consider and approve the audited financial results of the Company for the quarter and the financial year ended 31 March 2013.

4th March 2013
APPOINTMENT OF MR VIJAY KUMAR GARG, AS ADDITIONAL DIRECTOR AND WHOLE TIME DIRECTOR

The Board of Directors has approved the appointment of Mr Vijay Kumar Garg, as Additional Director and Whole time Director for a period of three years with effect 2 March 2013 subject to retirement by rotation by circulation pursuant to Section 289 of the Companies Act, 1956 on 2 March 2013. He is B.Sc. (Chemistry), MBA and has done EPIB (One year PG Course) from Indian Institute of Management Kolkata and has in his credit about 20 years experience in commercial activities of chemical and pharmaceutical products and has also international exposure in the industry.

14th February 2013
OUTCOME OF THE BOARD MEETING HELD ON 14 FEBRUARY 2013

Board of Directors in its meeting held on today i.e. 14 February 2013 has approved the Un-audited financial results for the quarter and nine months ended 31 December 2012. The net sales for the quarter ended 31 December 2012 is 117.05 crore against 130.76 crore during corresponding quarter ended 31 December 2011. The Profit before interest & depreciation has increased by 27.14% to 23.93 crore during the quarter under review against 18.82 crore during the corresponding quarter ended 31 December 2011 and Profit after tax 0.35 crore during the quarter ended 31 December 2012.

5th February 2013
NOTICE OF THE BOARD MEETING 05 FEBRUARY 2013

The meeting of the Board of Directors is scheduled to be held on Thursday, 14 February 2013 inter-alia to consider the un-audited financial results of the Company for the quarter ended 31 December 2012.

10th November 2012
OUTCOME OF THE BOARD MEETING HELD ON 10 NOVEMBER 2012

The Board of Directors in its meeting held on today i.e. 10 November 2012 has approved the following Un-audited financial results for the quarter/half year ended 30 September 2012 The net sales for the quarter ended 30 September 2012 is 104.20 crore against 103.61 crore during corresponding quarter ended 30 September 2011. The Profit before interest & depreciation has increased by 22.27% to 22.39 crore during the quarter under review against 18.31 crore during the corresponding quarter ended 30 September 2011 and Profit after tax 0.48 crore during the quarter ended 30 September 2012.

31st October 2012
NOTICE OF THE BOARD MEETING

The meeting of the Board of Directors is scheduled to be held on Saturday, 10 November 2012 inter-alia to consider the un-audited financial results of the Company for the quarter and half year ended 30 September 2012.

30th September 2012
OUTCOME OF THE 25TH ANNUAL GENERAL MEETING HELD ON 30 MAY 2012

The members of the Company in its Annual General Meeting held on 29 September 2012 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the following matters by way of passing the ordinary/special resolutions unanimously: 1. Adoption of the audited Balance Sheet as at 31 March 2012 and Profit & Loss Account for the year ended on that date alongwith the Reports of the Auditors and Directors thereon. 2. Appointment of Dr M A Zahir as director of the Company, who retires by rotation and being eligible offered himself for re-appointment. 3. Appointment of Mr Chandra Mohan as director of the Company, who retires by rotation and being eligible offered herself for re-appointment. 4. Re-appointment of M/s S C Vasudeva & Co., Chartered Accountants, New Delhi as Statutory Auditors of the Company 5. Appointment and payment of remuneration to Mr Narender Kumar Pundir as Director (Commercial) of the Company from 31 March 2012 to 14 August 2012, who was appointed as an Additional Director of the Company. 6. Re-appointment of Sh Varinder Gupta as Managing Director of the Company for next three year w.e.f. 0I September 2012 to 31 August 2015. 7. Approval to re-classify the Authorised Share Capital and alteration in the Memorandum of Association of the Company. 8. Approval to alteration in the Article of Association of the Company.

1st September 2012
OUTCOME OF THE BOARD MEETING HELD ON 01 SEPTEMBER 2012

The Board of Directors in its meeting held on Today i.e. 01 September 2012 has approved the following matters:   1.    Re-classifies the Authorised Share Capital of the Company from 54 crores consisting of        4.9 crores equity share of 10 each  and 50 lacs  preference share of 10 each  to       3.2 crores equity share of 10 each and 2.2 crores preference shares of 10 each and to recommend the same to the members for their approval at the ensuing Annual General Meeting of the Company.     2.    Issue of 26,64 ,000 equity shares of face value 10/- each as per SEBI Regulations to the Promoters / Promoter group companies on the Preferential basis and to recommend the same to the members for their approval at the ensuing Annual General Meeting of the Company. 3.    Issue of 1,70,00,000 Non Convertible, Non Cumulative ,1% Redeemable  Preference Shares  of 10 each as per SEBI Regulations to the Promoters / Promoter group companies and other person on the Preferential basis and to recommend the same to the members for their approval at the ensuing Annual General Meeting of the Company.    

1st September 2012
NOTICE OF 25TH ANNUAL GENERAL MEETING

Notice is hereby given that the Twenty-fifth Annual General Meeting of the Members of the Company will be held on Saturday, the 29th day of September, 2012 at 10.00 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which is being posted to the Members separately at their registered addresses in India. Notice is also hereby given pursuant to Section 154 of the Companies Act, 1956 that the Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, the 25th day of September, 2012 to Saturday, the 29th day of September, 2012 (both days inclusive).

14th August 2012
OUTCOME OF THE BOARD MEETING HELD ON 14 AUGUST 2012

The Board of Directors in its meeting held on today i.e. 14 August 2012 has approved the following 1.Un-audited financial results for the quarter ended 30 June 2012 The net sales for the quarter ended 30 June 2012 is 124.77 crore against 112.89 crore during corresponding quarter ended 30 June 2011. The Profit before interest & depreciation has increased by 31.21% to 23.25 crore during the quarter under review against 17.72 crore during the corresponding quarter ended 30 June 2011 and Profit after tax 0.69 crore during the quarter ended 30 June 2012. 2.The twenty-fifth Annual General Meeting of the members of IOL Chemicals and Pharmaceuticals Limited will be held on Saturday, 29 September 2012 at 10:00 AM at the Registered Office of the Company; Trident Complex, Raikot Road, Barnala, Punjab. 3.The Register of Members and share transfer books will remain closed from Tuesday, 25 September 2012 to Saturday, 29 September 2012 (both days inclusive) for the purpose of Annual General Meeting of the Company. 4.Re-appointment of Sh. Varinder Gupta as Managing Director of the Company with effect from 01st September 2012.

30th May 2012
OUTCOME OF THE BOARD MEETING HELD ON 30 MAY 2012

Board of Directors in its meeting held on today i.e. 30 May 2012 has considered and approved the Audited accounts for the quarter and the financial year ended 31 March 2012.  

2nd May 2012
OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 02 MAY 2012

This is to inform you that the Share Allotment Committee of the Board of Directors in its meeting held on 02.05.2012 allotted 4,34,500 equity shares of 10/- each to the shareholders of G Drugs and Pharmaceuticals Limited in terms of the Exchange Ratio 1 (one) equity share of the Company of the face value of 10/- each credited as fully paid up at par for every 20 (Twenty) fully paid up equity shares of 10/- each held by such equity shareholders of the G Drugs and Pharmaceuticals Limited as sanction by BIFR Order dated 15 March 2012 , which will be locked in for a period of three years from the date of allotment . Consequent upon the issue of the above 4,34,500 equity shares, the total paid-up capital of the company stands increased to 2,61,51,164 fully paid equity shares of 10/- each .

19th April 2012
RECORD DATE

This is to inform you that the Company has fixed 01 May 2012 as the Record Date for the purpose of determining the Shareholders of G Drugs and Pharmaceuticals Limited (Transferor Company), who would be entitled to the Shares of IOL Chemicals and Pharmaceuticals Limited (Transferee Company), in terms of the Exchange Ratio 1 (one) equity share of Transferee Company of the face value of 10/- credited as fully paid up at par for every 20 (Twenty) fully paid up equity shares of 10/- held by such equity shareholders of the Transferor Company as sanction by BIFR Order dated 15 March 2012.

31st March 2012
OUTCOME OF THE BOARD MEETING HELD ON 31 MARCH 2012

The Board of Directors in its meeting held on 31 March 2012 has approved the following matters: 1. Considered and approved the resignation of Sh Kanwal Pushkarnath Pandita as director of the Company w.e.f 31 March 2012. 2. Considered and approved the resignation of Smt Dimple Gupta as director of the Company w.e.f 31 March 2012 3. The Board has approved the appointment of Sh Narender Kumar Pundir, as Additional Director and Director (Commercial) w.e.f 31 March 2012. He has about 26 years experience in commercial activities of chemical products and has also international exposure in the industry. He holds masters degree in science and post graduate diploma in business management

11th February 2012
OUTCOME OF THE BOARD MEETING HELD ON 11 FEBRUARY 2012

Board of Directors in its meeting held on today i.e. 11 February 2012 has approved the Un-audited financial results for the quarter/ nine months ended 31 December 2011.The net sales and other income of the Company for the quarter ended 31 December 2011 increased by 28% to 130.92 crore from 102.07 crore during corresponding quarter of the previous year. The Earning before interest, depreciation and tax (EBIDT) for the quarter ended 31 December 2011 went up by 5% to 18.82 crore against 17.94 crore reported in corresponding quarter of the previous year.

14th November 2011
OUTCOME OF THE BOARD MEETING HELD ON 14 NOVEMBER 2011

The Board of Directors in its meeting held 14 November 2011 has approved the Un-audited financial results for the quarter/half year ended 30 September 2011 The net sales for the quarter ended 30 September 2011 is 103.61 crore against 89.25 crore during corresponding quarter ended 30 September 2010. The Profit before interest & depreciation has increased by 12.67% to 18.32 crore during the quarter under review against 16.26 crore during the corresponding quarter ended 30 September 2010. The Company earned cash accrual of 7.57 crore during the quarter under review against 7.47 crore during the corresponding quarter ended 30 September 2010. Profit after Tax earned 1.57 crore during the quarter ended 30 September 2011.

24th September 2011
OUTCOME OF THE 24TH ANNUAL GENERAL MEETING HELD ON 24 SEPTEMBER 2011

This is to inform you that the members of the Company in its Annual General Meeting held on 24 September 2011 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the following matters by way of passing the ordinary/special resolutions unanimously: 1. Adoption of the audited Balance Sheet as at 31 March 2011 and Profit & Loss Account for the year ended on that date alongwith the Reports of the Auditors and Directors thereon. 2. Appointment of Mr Ravi Pratap Singh as director of the Company, who retires by rotation and being eligible offered himself for re-appointment. 3. Appointment of Mr Yogesh Goel as director of the Company, who retires by rotation and being eligible offered herself for re-appointment. 4. Re-appointment of M/s S C Vasudeva & Co., Chartered Accountants, New Delhi as Statutory Auditors of the Company 5. Appointment of Mr Kanwal Pushkarnath Pandita as a director of the Company liable to retire by rotation, who was appointed as an additional director on the Board w.e.f. 16.08.2010. 6. Appointment of Mr Vijay Singla as a director of the Company liable to retire by rotation, who was appointed as an additional director on the Board w.e.f. 11.07.2011. 7. Approval to revise the remuneration of Mr Varinder Gupta, Managing Director of the Company with effect from 11 August 2010 for his remaining tenure i.e. upto 31 August 2012. 8. Approval to revise the remuneration of Mr R K Thukral, Executive Director of the Company with effect from 11 August 2010 upto 11 July 2011. 9. Appointment of Mr Vijay Singla as Director (Works) of the Company for a period of five years w.e.f 11.07.2011 10. Approval to the merger of G Drugs and Pharmaceuticals Limited subject to the approval of BIFR with the Company. 11. Approval to issue and allot upto an aggregate of 4,34,500 Equity shares of the face value of 10 each to persons who are members of G Drugs and Pharmaceuticals Limited in the share exchange ratio of 1:20 as per the scheme to be approved by BIFR.

12th August 2011
NOTICE OF 24TH ANNUAL GENERAL MEETING

Notice is hereby given that the Twenty-forth Annual General Meeting of the Members of the Company will be held on Saturday, the 24th day of September, 2011 at 10.00 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which is being posted to the Members separately at their registered addresses in India. Notice is also hereby given pursuant to Section 154 of the Companies Act, 1956 that the Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, the 20th day of September, 2011 to Saturday, the 24th day of September, 2011 (both days inclusive).

12th August 2011
OUTCOME OF THE BOARD MEETING HELD ON 12 AUGUST 2011

The Board of Directors in its meeting held 12 August 2011 has approved the Un-audited financial results for the quarter ended 30 June 2011 The net sales for the quarter ended 30 June 2011 is 112.89 crore against 91.19 crore during corresponding quarter ended 30 June 2010. The Profit before interest & depreciation has increased by 10.13% to 17.72 crore during the quarter under review against 16.09 crore during the corresponding quarter ended 30 June 2010. The Company earned cash accrual of 7.11 crore during the quarter under review against 7.18 crore during the corresponding quarter ended 30 June 2010. Profit after Tax earned 0.97 crore during the quarter ended 30 June 2011.

11th July 2011
OUTCOME OF THE BOARD MEETING HELD ON 11 JULY 2011

The Board of Directors in its meeting held on 11 July 2011 has approved the following matters: 1. Considered and approved the resignation of Sh R K Thukral as the Executive director of the Company w.e.f 11 July 2011. 2. The Board has approved the appointment of Sh Vijay Singla, BE – Chemical Engineer as Additional Director and Director (Works) w.e.f 11 July 2011

28th June 2011
RESEARCH & DEVELOPMENT RECOGNITION

IOLCP's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of Scientific & Industrial Research), Ministry of Science & Technology, New Delhi.

21st May 2011
OUTCOME OF THE BOARD MEETING HELD ON 21 MAY 2011

The Board of Directors in its meeting held on 21 May 2011 has approved the following matters: 1. Considered and approved the Audited Annual accounts for the year ended 31 March 2011 subject to the adoption by the members in its Annual General Meeting. 2. Considered and approved the resignation of Dr (Mrs) H K Bal as the director of the Company.

13th May 2011
NOTICE OF THE BOARD MEETING

The meeting of Board of Directors is scheduled to be held on Saturday, 21 May 2011 inter-alia to consider the audited financial results of the company for the year ended 31 March 2011

15th April 2011
CREDIT RATING

The Credit Analysis & Research Ltd (CARE) has assigned/retained the ‘CARE BBB’ for Long Term Facilities and ‘PR2’ for Short Term Facilities credit rating of the company

22nd March 2011
IOLCP ASSIGNED D&B D-U-N-S® NUMBER : 65-004-7801

Dun & Bradstreet Information Services India Private Limited has assigned D&B D-U-N-S® Number : 65-004-7801 to IOL Chemicals and Pharmaceuticals Limited

8th February 2011
OUTCOME OF THE BOARD MEETING HELD ON 8 FEBRUARY 2011

The Board of Directors in its meeting held on today i.e. 8 February 2011 has approved the Un-audited financial results for the quarter/ nine months year ended 31 December 2010 The net sales and other income of the Company for the quarter ended 31 December 2010 increased by 18% to 102.07 crore from 6.22 crore during corresponding quarter of the previous year. The Earning before interest, depreciation and tax (EBIDT) for the quarter ended 31 December 2010 went up by 40% to 17.94 crore against 12.79 crore reported in corresponding quarter of the previous year.

23rd August 2010
OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 23 AUGUST 2010

The Share Allotment Committee of the Board in its meeting held on 23 August 2010 has allotted 15,00,000 (fifteen lacs) warrants, carrying an option to the holder of such warrants to subscribe to one equity share of 10/- at premium of 68 per share for every warrant held, within 18 months from the date of allotment of the warrants, to the G Consultants and Fabricators Limited, Non promoter, on preferential basis in accordance with the applicable laws

14th August 2010
OUTCOME OF THE ANNUAL GENERAL MEETING HELD ON 14 AUGUST 2010

The members of the Company in its Annual General Meeting held on 14 August 2010 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the following matters by way of passing the ordinary/special resolutions with or without modifications unanimously: 1. Adoption of the audited Balance Sheet as at 31 March 2010 and Profit & Loss Account for the year ended on that date alongwith the Reports of the Auditors and Directors thereon. 2. Appointment of Sh Chandra Mohan as director of the Company, who retires by rotation and being eligible offered himself for re-appointment. 3. Appointment of Mrs Dimple Gupta as director of the Company, who retires by rotation and being eligible offered herself for re-appointment. 4. Re-appointment of M/s S C Vasudeva & Co., Chartered Accountants, New Delhi as Statutory Auditors of the Company 5. Issue of 15,00,000 (Fifteen lac) warrants, carrying the option to the holders of such warrants to subscribe to one equity share of face value of 10/- at premium of 68/- per share for every warrant held, within a period of 18 months from the date of allotment of the warrants, to G Consultants and Fabricators Limited, Non-Promoter Company, on preferential basis in accordance with the applicable laws.

11th August 2010
OUTCOME OF THE BOARD MEETING HELD ON 11 AUGUST 2010

1. The Board has approved the appointment of Dr Kanwal P Pandita, as Additional Director w.e.f 16 August 2010. 2. The Board has approved un-audited financial results for the quarter ended 30 June 2010 and noted Net Sales for the quarter ended 30 June 2010 is 91.19 crore against 88.05 crore during corresponding quarter ended 30 June 2009. The Profit before interest & depreciation has increased by 89.74% to 16.09 crore during the quarter under review against 8.48 crore during the corresponding quarter ended 30 June 2009.The Company earned cash accrual of 7.48 crore during the quarter under review against 4.45 crore during the corresponding quarter ended 30 June 2009. Profit after Tax earned 1.00 crore during the quarter ended 30 June 2010.

19th June 2010
OUTCOME OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON 19 JUNE 2010

The members of the Company in its Extra-ordinary General Meeting held on 19 June 2010 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the Increase in the Authorised Share Capital of the Company from 35 crore divided into 3 crore equity shares of 10/- each and 50 lacs preference shares of 10/- each to 45 crore divided into 4 crore equity shares of 10/- each and 50 lacs preference shares of 10/- each & consequent amendment in the Memorandum and Articles of Association of the Company by way of passing the ordinary/special resolutions unanimously:

29th May 2010
OUTCOME OF THE BOARD MEETING HELD ON 29 MAY 2010

1. The Board of Directors in its meeting held on 29 May 2010 has approved the Annual accounts for the year ended 31 March 2010 subject to the adoption by the members in its Annual General Meeting. 2. The Board has approved CAPAX of 130 crore for capacity enhancement and diversification for more pharmaceuticals product.

28th May 2010
OUTCOME OF THE ALLOTMENT COMMITTEE MEETING HELD ON 28 MAY 2010

The Allotment Committee of the Board in its meeting held on 28 May, 2010 has decided to close the FCCB issue on 28 May, 2010 being the closing date, as the FCCB issue of US$5 million have been fully subscribed.

17th May 2010
OUTCOME OF THE ALLOTMENT COMMITTEE MEETING 17.05.2010

Allotment Committee of the Board in its meeting held on 17 May, 2010 has approved and fixed the Wednesday, 19 May, 2010 as the date of opening of issue of US$5 million, Zero Coupon Unsecured Foreign Currency Convertible Bonds (subject to an Option to issue an additional US$10 million of such bonds) in the International Market.

15th May 2010
OUTCOME OF THE BOARD MEETING 15.05.2010

Board of Directors in its meeting held on 15.05.2010 has approved the following matters: 1. Issue of US$5 million, Zero Coupon Unsecured Foreign Currency Convertible Bonds (subject to an Option to issue an additional US$10 million of such bonds) in the International Market and authorized the Committee of the Board to do all acts including to fix the date of opening and closing of the issue of abovesaid securities. 2. Increase in the authorized share capital of the Company from 35 crore to 45 crore, subject to the approval of shareholders.

9th January 2010
OUTCOME OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON 09.01.2010

The members of the Company in its Extra-ordinary General Meeting held on January 9, 2010 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the following matters by way of passing the ordinary/special resolutions unanimously: 1. Increase in the Authorised Share Capital of the Company from 30 crores to 35 crores & consequent amendment in the Memorandum and Articles of Association of the Company 2. Issue of 15,00,000 (Fifteen lac) equity shares of face value of 10/- each at a premium of 46/- per share aggregating to 8,40,00,000 (Rupees eight crore forty lac only) to NM Merchantiles Limited, Promoters/ Promoters Companies. 3. Issue of 30,00,000 (Thirty lac) warrants, carrying the option to the holders of such warrants to subscribe to one equity share of face value of 10/- at premium of 46/- per share for every warrant held, within a period of 18 months from the date of allotment of the warrants, to the following Promoters/ Promoters Companies, on preferential basis in accordance with the applicable laws. a) 10,00,000 (ten lac) warrants to NM Merchantiles Limited b) 10,00,000 (ten lac) warrants to NCG Enterprises Limited c) 10,00,000 (ten lac) warrants to IOL Lifesciences Limited.”

10th December 2009
OUTCOME OF THE BOARD MEETING HELD ON 10.12.2009

The Board of Directors in its meeting held on 10.12.2009 has approved the following matters: 1. Increase in the Authorised Share Capital of the Company from 30 crores to 35 crores. 2. Issue of 15,00,000 equity shares and 30,00,000 equity warrants, carrying an option to the holder of such warrants to subscribe to one equity share of 10/- for every warrant held, within 18 months from the date of allotment of the warrants at the price to be fixed as per SEBI Regulations to the Promoters / Promoter group companies on the Preferential basis. 3. Convening of Extra-ordinary General Meeting on 09.01.2010. 4. Commencement of trial production of Iso-butyl Benzene, which is basic raw material for Ibuprofen.

10th December 2009
CONVENING OF EXTRA-ORDINARY GENERAL MEETING ON 09TH JANUARY, 2010

The Extra-ordinary General Meeting of the Members of the Company will be held on Saturday, the 09th day of January, 2010 at 10.00 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which has been posted to the Members separately at their registered addresses in India.

31st October 2009
OUTCOME OF THE BOARD MEETING HELD ON 31.10.2009

The Board of Directors in its meeting held on 31.10.2009 approved the Un–audited financial results for the quarter/ half year ended September 30, 2009

18th August 2009
CONVENING OF ANNUAL GENERAL MEETING ON 12TH SEPTEMBER, 2009

The Twenty-second Annual General Meeting of the Members of the Company will be held on Saturday, the 12th day of September, 2009 at 10.00 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which has been posted to the Members separately at their registered addresses in India. Further. the Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, the 8th day of September, 2009 to Saturday, the 12th day of September, 2009 (both days inclusive).

30th June 2009
OUTCOME OF THE BOARD MEETING HELD ON 30.06.2009

The Board of Directors in its meeting held on 30th June, 2009 approved the Annual accounts for the year ended 31st March, 2009 subject to the adoption by the members in its Annual General Meeting . The annual net sales and other income of the Company has decreased by 5% to 30519.36 lacs from 31900.38 lacs. The Profit before interest & depreciation has slightly declined by 2% to 3601.88 lacs during the year under review against 3675.40 lacs during the previous year. However, the net profit after tax has increased by 3% from 1236.33 lacs to 1269.43 lacs during the year under review.

28th May 2009
COMPANY HAS COMMENCED THE MANUFACTURING OPERATIONS

Company has commenced the manufacturing operations of Mono-chloro Acetic Acid (MCA) with the capacity of 7200 TPA, Acetyl Chloride with the capacity of 5200 TPA during the month of May, 2009 as partial completion of its ongoing Expansion cum Backward and Forward Integration project. These products are being used as raw materials for the manufacture of its API Ibuprofen as Backward Integration for its pharma division and as Forward Integration for its chemical division as these two products are being produced by using existing chemicals i.e. Acetic Anhydride and Acetic Acid.

28th May 2009
IOL CHEMICALS & PHARMACEUTICALS ALL SET TO EMERGE AS INDIAS LARGEST IBUPROFEN MANUFACTURER

IOL Chemicals and Pharmaceuticals Limited (IOLCP) has commenced the manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively, making it the second largest producer of these chemicals in the country. Both of these chemicals will be used by the company as raw materials for its most popular pharmaceutical product, Ibuprofen. This development has made IOLCP the only Ibuprofen manufacturer in India to have its own captive raw material production unit. Additionally, the enhanced production capacity of Ibuprofen from 3600 TPA to 6000 TPA will make IOLCP the largest producer of the bulk drug (Ibuprofen) in India by the end of this year. IOLCP is also installing another captive co-generation plant of 4 MW, which will take its cogeneration capacity to 17MW to meet the increased energy demand of its production units. The whole project is expected to be completed by the end of December, 2009.

12th May 2009
IOLCP GETS STAR EXPORT HOUSE STATUS FROM MINISTRY OF COMMERCE AND INDUSTRY

Company has been accorded the coveted status of Star Export House in accordance with the provisions of the Foreign Trade Policy, 2004-2009 by the Ministry of Commerce and Industry, Department of Commerce, Government of India, which makes the company eligible for many privileges that will help enhance its business and exports revenues.

5th May 2009
PUNJAB STATE SAFETY AWARD 2008 (FIRST PRIZE IN CHEMICAL SECTOR)

Company has received Punjab State Safety Award 2008 (First Prize in Chemical Sector) for Largest Reduction in Frequency Rate of Accident in Chemical Industry, for more than five lac man hours group

27th April 2009
FY 09 RESULTS BY JUN 30, 2009

Company will publish its Audited Financial Results for the quarter / financial year ended March 31, 2009 within three months from the end of the financial year i.e. on or before June 30, 2009

21st April 2009
OUTCOME OF ALLOTMENT COMMITTEE MEETING 21.04.2009

Allotment Committee of the Board of Directors in its meeting held on April 21, 2009, has allotted 30,66,664 equity shares of 10/- each consisting 12,00,000 equity shares allotted to M/s. Mayadevi Polycot Ltd, Promoter on the conversion of warrants and 18,66,664 equity shares allotted to M/s. indiaSTAR (Mauritius) Ltd, M/s. G S Auto Leasing Ltd and M/s. Shivalik Securities Ltd, Non-promoters on the conversion of fully convertible debentures. Consequent upon the issue of the above 30,66,664 equity shares, the total paid-up capital of the Company stands increased to 2,12,16,664 fully paid equity shares of 10 each.

9th April 2009
CREDIT RATINGS

Credit Analysis and Research Ltd (CARE) with reference to the exiting bank facilities of the Company has retained a "CARE BBB" (triple B) rating to the long term bank facilities aggregating to 225.8 crores of the Company including enhanced facilities of 10 crores. Facilities with this rating are considered to offer moderate safety for timely servicing of debt obligation. Further CARE has retained a "PR2" ( PR two ) rating to the short term bank facilities aggregating to 55 crore of the Company including enhanced facilities of 25 crores. Facilities with this rating would have adequate capacity for timely payment of short term debt obligation.

4th March 2009
CHANGE IN DIRECTORATE

IDBI Bank Ltd vide its letter dated February 16, 2009 has appointed Sh. Parminder Singh Cheema on the Board of the Company as its Nominee Director in place of Smt. Lalita Kapur with effect from March 02, 2009.

20th February 2009
OUTCOME OF ALLOTMENT COMMITTEE MEETING 20.02.2009

Allotment Committee of the Board of Directors in its meeting held on February 20, 2009, has allotted 4,54,000 equity shares of 10/- each to the following persons for cash at a premium of 32/- per share on the conversion of warrants issued on August 21, 2007

12th February 2009
COVETED CERTIFICATIONS FOR EXPORTS OF ITS PHARMA PRODUCT, IBUPROFEN

Company has received coveted certifications for exports of its pharma product, Ibuprofen, to various countries.

15th December 2008
NATIONAL ENERGY CONSERVATION AWARD 2008

IOL Chemicals and Pharmaceuticals Limited (IOLCP), has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources. Since 2005, IOLCP has won the National Energy Conservation Award consecutively fourth time. Mr. R K Thukral, Executive Director, IOLCP received this award from Mr. Sushil Kumar Shinde, Hon’ble Minister of Power, Government of India at a special felicitation ceremony held on 14th December, 2008 at New Delhi.

12th December 2008
ACCREDITATION CERTIFICATE YOICHI MASUZOE, JAPAN

The Company has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan

31st October 2008
OUTCOME OF THE BOARD MEETING


The Board of Directors in its meeting held on 31.10.2008 has approved the following

• The Board has also approved the appointment of Sh Yogesh Goel, as Additional Director w.e.f 31.10.2008
• Unaudited financial results for the quarter/half year ended 30th September, 2008 and noted that the Profit after Tax for the quarter ended September 30, 2008, went up by 25.53 % to 4.16 crores from 3.32 crores reported in the corresponding quarter of the previous year. The Operating Profit for the quarter ended September 30, 2008, went up to 8.25 crores against 8.12 crores reported in the corresponding quarter ended September 30, 2007

30th October 2008
OUTCOME OF THE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 30.10.2008

The Allotment Committee of the Board of Directors in its meeting held on 30.10.2008 allotted 24,30,500 equity shares to the Promoter and Non-Promoters.Consequent upon the same, the total paid-up capital of the company stands increased to 1,76,96,000 fully paid equity shares of 10 each.

20th September 2008
OUTCOME OF THE 21ST ANNUAL GENERAL MEETING HELD ON 20.09.2008


The members of the Company in its Annual General Meeting held on 20th September, 2008 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the following matters by way of passing the ordinary/special resolutions with or without modifications unanimously:

• Adoption of the audited Balance Sheet as at 31st March, 2008 and Profit & Loss Account for the year ended on that date alongwith the Reports of the Auditors and Directors thereon.
• Appointment of Sh. Varinder Gupta as director of the Company, who retires by rotation and being eligible offered himself for re-appointment.
• Appointment of Dr. M A Zahir as director of the Company, who retires by rotation and being eligible offered himself for re-appointment.
• Appointment of Sh Chandra Mohan as director of the Company, who retires by rotation and being eligible offered himself for re-appointment.
• Appointment of Dr. (Mrs) H K Bal as director of the Company, who retires by rotation and being eligible offered herself for re-appointment.
• Appointment of Mrs Dimple Gupta as director of the Company, who retires by rotation and being eligible offered herself for re-appointment.
• Appointment of M/s S C Vasudeva & Co. , Chartered Accountants, New Delhi as Statutory Auditors of the Company in the place of M/s K K Kapoor & Associates, Chartered Accountants, the retiring Auditors of the Company as they have shown their unwillingness to be re-appointed as Statutory Auditors of the Company.
• Appointment of Sh Ravi Pratap Singh as a director of the Company, who was appointed as an additional director on the Board w.e.f. 31.07.2008.
• Appointment of Sh R K Thukral as a director of the Company, who was appointed as additional director on the Board w.e.f 31.07.2008.
• Appointment of Sh R K Thukral as an executive director of the Company for a period of five years w.e.f 31.07.2008.
• Authorisation of the Board of Directors of the Company to borrow moneys not exceeding 500 crores (Rupees five hundred Crores).
• Authorisation of the Board of Directors of the Company for the creation of charges on the immovable/movable assets of the Company for securing the borrowings not exceeding 500 crores (Rupees five hundred Crores).
• Approval to the alteration in Articles of Association of the Company.
• Approval to the Issue of Securities to Qualified Institutional Buyers (QIBs) in accordance with the provisions of Chapter XIII A of SEBI (DIP) Guidelines,2000 for an amount not exceeding 100 crores (Rupees One hundred crores) .
• Approval to the raising of resources through issue of securities in the international market upto US Dollars 25 (twenty five) Millions.
• Approval to the increase in sitting fees of Non Executive directors for attending the Board and Committee meetings to 7,500 and 5,000 respectively.

6th September 2008
OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 06.09.2008

The Allotment Committee of the Board of Directors in its meeting held on 06.09.2008 allotted 18,85,500 equity shares to the promoters and non promoters. Consequent upon the same, the total paid-up equity capital of the company stands increased to 1,52,65,500 fully paid equity shares of 10 each .

27th August 2008
CONVENING OF ANNUAL GENERAL MEETING ON 20TH SEPTEMBER, 2008

Twenty-first Annual General Meeting of the Members of the Company will be held on Saturday, the 20th day of September, 2008 at 10 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which has been posted to the Members separately at their registered addresses. Further, the Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, the 16th day of September, 2008 to Saturday, the 20th day of September, 2008 (both days inclusive)

31st July 2008
OUTCOME OF THE BOARD MEETING

The Board of Directors in its meeting held on 31st July, 2008 approved the following matters:
1. The Board has approved the appointment of Sh R K Thukral as Additional Director and Executive Director. He is a Science Graduate having more than 30 years experience in the field of chemical industry.
2. The Board has also approved the appointment of Sh Ravi Pratap Singh, USA citizen, as Additional Director. He is representative of indiaSTAR (Mauritius) Limited, FDI. He has a BS in Mechanical Engineering from University of Delhi and an MBA from Columbia University.
3. The Board considered and approved the Un-audited financial results for the quarter ended 30th June, 2008.

5th May 2008
OUTCOME OF THE BOARD MEETING

The Board of Directors in its meeting held on today that is 5th May, 2008 approved the following matters :
1. Annual accounts for the year ended 31st March, 2008 subject to the adoption by the members in its Annual General Meeting . The Compny has reported turnover of 361.35 crores against 231.87 crores in the previous year recording increase of 56 %. The operating profit of the company has recorded rise of 93 % over that of the previous year from 19.15 crores to 37.02 cores during the year. The company has achieved net profit after tax of 12.36 crores during the current year against 7.55 crores n the previous year showing an increase of 64%.
2. Issue of Securities to Qualified Institutional Buyers (QIBs) in accordance with the provisions of Chapter XIII A of SEBI (DIP) Guidelines,2000 for an amount not exceeding 50 crores (Rupees Fifty Crores).
3. Raising of sources through issue of securities in the international market upto United State Dollars 10 (ten) Millions.
4. Amendment in articles of association of the company necessitated due to the buy back of shareholding from Punjab State Industrial Development Corporation Limited , state level financial institution by the promoters of the company.

5th May 2008
COMBINED CODE OF CORPORATE GOVERNANCE AND CONDUCT

Due to change in the clause 49 of Listing Agreement and present condition it is require to modify the Combined Code of Corporate Governance and Conduct of the Company. Copy of revised Code of Conduct is available in this web site.

22nd October 2007
OUTCOME OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON 22.10.2007

The members of the Company in its Extra-ordinary General Meeting held on 22.10.2007 approved the issue of:
a) upto 13,30,000 (Thirteen Lac Thirty Thousand) Equity Shares of face value of 10/- each at a premium of 65/- per share aggregating to 9,97,50,000 (Rupees nine crore ninety seven lac fifty thousand only) to M/s. Indiastar (Mauritius) Limited, Non-promoter of the Company.
b) upto 13,99,998 (Thirteen Lac Ninity Nine Thousand Nine Hundred Ninety Eight) unsecured 10% fully convertible debentures (FCDs) of 100 each aggregating to 13, 99, 99,800 (Rupees Thirteen Crores Ninity Nine Lac Ninety Nine Thousand Eight Hundred only) at an Interest rate of 10% p.a. payable monthly convertible in one and more trenches within a period of 18 months from the date of allotment into equity shares of face value of 10 each at a premium of 65 per share to Indiastar (Mauritius) Limited, Non-promoter of the Company .
c) upto 23,00,000 (twenty three lacs) warrants ,carrying an option to the holder of such warrants to subscribe to one equity share of 10/- at premium of 65/- per share for every warrant held, within 18 months from the date of allotment of the warrants, to following persons, on preferential basis in accordance with the applicable law:
i) 12,00,000 (twelve lacs) warrants to Mayadevi Polycot Limited, Promoter of the Company. ii) 11,00,000 (Eleven lacs) warrants to Indiastar (Mauritius) limited, Non-promoter of the Company.”
in accordance with the provisions of Companies Act,1956 SEBI guidelines and the other applicable laws.

22nd October 2007
OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 22.10.2007

The following securities has been allotted to persons mentioned below by the Share Allotment Committee of the Board in its meeting held on 22.10.2007
a) 13,30,000 (Thirteen Lac Thirty Thousand) Equity Shares of face value of 10/- each at a premium of 65/- per share aggregating to 9,97,50,000 (Rupees nine crore ninety seven lac fifty thousand only) to M/s. IndiaSTAR (Mauritius) Limited, Non-promoter of the Company.
b) 13,99,998 (Thirteen Lac Ninety Nine Thousand Nine Hundred Ninety Eight) unsecured 10% fully convertible debentures (FCDs) of 100 each aggregating to 13, 99, 99,800 (Rupees Thirteen Crores Ninity Nine Lac Ninety Nine Thousand Eight Hundred only) at an Interest rate of 10% p.a. payable monthly convertible in one and more trenches within a period of 18 months from the date of allotment into equity shares of face value of 10 each at a premium of 65 per share to IndiaSTAR (Mauritius) Limited, Non-promoter of the Company .
c) 23,00,000 (twenty three lacs) warrants ,carrying an option to the holder of such warrants to subscribe to one equity share of 10/- at premium of 65/- per share for every warrant held, within 18 months from the date of allotment of the warrants, to following persons, on preferential basis in accordance with the applicable law:
i) 12,00,000 (twelve lacs) warrants to Mayadevi Polycot Limited, Promoter of the Company.
ii) 11,00,000 (Eleven lacs) warrants to IndiaSTAR (Mauritius) limited, Non-promoter of the Company.”
in accordance with the provisions of Companies Act,1956 SEBI guidelines and the other applicable laws.
These equity shares/FCDs/warrants will be on the following terms and condition:
Equity shares
1. The equity shares allotted on preferential basis shall be locked-in for a period of one year from the date of their allotment.
FCDs
1. The FCDs will be compulsory converted in one or more trenches within a period of 18 months from the date of allotment into equity shares of face value of 10/- each at a premium of 65/- per share..
2. Interest at the rate of 10% p.a payable monthly until the FCDs are converted into equity shares.
3. The FCDs allotted on preferential basis shall be locked-in for a period of one year from the date of their allotment. The lock in on shares acquired on conversion of FCDs shall be reduced to the extent the FCDs have already been locked-in.
Warrants
1. The warrants shall be attached with an option to subscribe and allotment of one equity share face value of 10/- at a premium of 65/- per share in share capital of the company within 18 months from the date of allotment of the warrants.
2. The warrants issued to M/s Mayadevi Polycot Limited , promoter of the company and to indiaSTAR (Mauritius) Limited ,non promoter of the company be locked in for a period of three years/ one year from the date of allotment respectively and the lock in on equity shares acquired by exercise of the warrants, shall be reduced to the extent the warrants have already been locked-in.
3. The amount deposit against the allotment of warrants will be forefeited in case we failed to exercise the option to subscribe for the allotment of the equity shares within the prescribed period.

15th October 2007
OUTCOME OF THE BOARD MEETING HELD ON 15.10.2007

The Board of Directors in its meeting held on 15.10.2007 considered and approved the un-audited financial results for the quarter/ half year ended 30th September, 2007.

25th September 2007
OUTCOME OF THE BOARD MEETING HELD ON 25.09.2007

The Board of Directors in its meeting held on 25th September , 2007 has reviewed the completion of existing capacities which are as follows :

a. of Acetic acid 50, 000 TPA

b. of Ethyl Acetate 33,000 TPA

c. of Acetic Anhydride 12,000 TPA

d. of Ibuprofen 3600 TPA

and set up of 4MW captive cogeneration plant

and now decided to undertake the expansion of the existing capacities, to set up manufacturing facilities to strengthen back ward and forward integration, cogeneration project with a total project cost of about 180 crores as per the following details to sustain and improve such growth:

in crores

1. Product: Acetic Acid

Existing capacity( TPA): 50,000

Proposed capacity (TPA):60,000



2. Product: Acetic Anhydride

Existing capacity( TPA) : 12,000

Proposed capacity (TPA): 18,000



3 Product: Ibuprofen

Existing capacity( TPA) 3,600

Proposed capacity (TPA) 7,200



4 Product Co generation project

Existing capacity: 4MW

Proposed capacity :14MW



5 Product:Monochloro Acetic Acid and Acetyl chloride

Existing capacity( TPA):-

Proposed capacity (TPA) 6,600 & 4,800



6. Product: Iso Butyl Benzene

Existing capacity( TPA):-

Proposed capacity (TPA) 6,000



The board has also discussed that the company has planned for further expansion of Ibuprofen due to the increasing export demand. Presently the company is exporting its finished products mainly in South Asian countries and the company is taking effective steps for getting USFDA approvals. The company is ideally located nearby to Baddi (H.P.), J & K, & Utrakhand, which are tax exempted zones and various pharmaceuticals companies are coming there for getting the benefits of tax exemption. The company will also be benefited from setting up of backward integration of Ibuprofen with setting up of Captive MCA, Acetyl Chloride and IBB plant. The setting of additional Co-generation plant will make the company self reliance for meeting its own energy requirements. Moreover, the major raw materials are easily available in the vicinity of Punjab & U.P.

The Board decided to complete these expansions by way of partly issuing convertible instruments , term loan from financial institutions and internal accruals .

The Board also approved to issue on preferential basis for cash consideration, in terms of SEBI Guidelines and other applicable laws :

a) upto 13,30,000 (Thirteen Lac Thirty Thousand) Equity Shares of face value of 10/- each at a premium of 65/- per share to M/s. Indiastar (Mauritius) Limited, Non-promoter of the Company, in accordance with the applicable law,

b) up to 13,99,998 (Thirteen Lac Ninity Nine Thousand Nine Hundred Ninety Eight) unsecured 10% fully convertible debentures (FCDs) of 100 each aggregating to 13, 99, 99,800 (Rupees Thirteen Crores Ninity Nine Lac Ninety Nine Thousand Eight Hundred only) at an Interest rate of 10% p.a. payable monthly convertible in one and more trenches within a period of 18 months from the date of allotment into equity shares of face value of 10 each at a premium of 65 per share to Indiastar (Mauritius) Limited, Non-promoter of the Company .

c) to issue, offer and allot up to 23,00,000 (twenty three lacs) warrants ,carrying an option to the holder of such warrants to subscribe to one equity share of 10/- at premium of 65/- per share for every warrant held, within 18 months from the date of allotment of the warrants, to following persons, on preferential basis in accordance with the applicable law:

i) 12,00,000 (twelve lacs) warrants to Mayadevi Polycot Limited, Promoter of the Company.

ii) 11,00,000 (Eleven lacs) warrants to Indiastar (Mauritius) limited, Non-promoter of the Company.”

on such terms and conditions including as to dividend, premium, conversion etc., as the Board may, in its absolute discretion, deem fit .

25th September 2007
CONVENING OF EXTRA-ORDINARY GENERAL MEETING ON 22.10.2007

The Extra-ordinary General Meeting of the Company to be held on Monday, the 22nd day of October, 2007 at 10.00 AM at its registered office situated at Trident Complex, Raikot Road, Barnala for approval of the members to issue on preferential basis for cash consideration, in terms of SEBI Guidelines and other applicable laws :

a) upto 13,30,000 (Thirteen Lac Thirty Thousand) Equity Shares of face value of 10/- each at a premium of 65/- per share to M/s. IndiaSTAR (Mauritius) Limited, Non-promoter of the Company, in accordance with the applicable law,

b) up to 13,99,998 (Thirteen Lac Ninity Nine Thousand Nine Hundred Ninety Eight) unsecured 10% fully convertible debentures (FCDs) of 100 each aggregating to 13, 99, 99,800 (Rupees Thirteen Crores Ninity Nine Lac Ninety Nine Thousand Eight Hundred only) at an Interest rate of 10% p.a. payable monthly convertible in one and more trenches within a period of 18 months from the date of allotment into equity shares of face value of 10 each at a premium of 65 per share to IndiaSTAR (Mauritius) Limited, Non-promoter of the Company .

c) to issue, offer and allot up to 23,00,000 (twenty three lacs) warrants ,carrying an option to the holder of such warrants to subscribe to one equity share of 10/- at premium of 65/- per share for every warrant held, within 18 months from the date of allotment of the warrants, to following persons, on preferential basis in accordance with the applicable law:

i) 12,00,000 (twelve lacs) warrants to Mayadevi Polycot Limited, Promoter of the Company.

ii) 11,00,000 (Eleven lacs) warrants to IndiaSTAR (Mauritius) limited, Non-promoter of the Company.”

on such terms and conditions including as to dividend, premium, conversion etc., in its absolute discretion as they deem fit .

22nd September 2007
OUTCOME OF THE ANNUAL GENERAL MEETING HELD ON 22.09.2007

The Members in its meeting held on 22.09.2007 has approved the following matters:

1. Considered & adopted the Balance Sheet as at 31.03.2007 and Profit & Loss Account for the year ended on that date alongwith the Auditors, report and Directors’ report. Mr Varinder Gupta , Chairman and Managing Director of the company has acquainted the shareholder with the last years and current years performance . He informed that the company has achieved net sales of 202.73crores during the year ended 31st March, 2007 against 153.16 crores during the year ended 31st March , 2006 recording increase of 32% over the last year . The profit after tax increased from 7.26 crores during the last year to 7.55 crores during the year under review .

2. Appointed Sh. Varinder Gupta as director of the Company Director, liable to retire by rotation

3. Appointed Dr. M A Zahir as director of the Company, liable to retire by rotation

4. Appointed Sh. Yogesh Goel as director of the Company, liable to retire by rotation

5. Appointed Dr. (Mrs) H K Bal as director of the Company, liable to retire by rotation

6. Appointed Sh. Chandra Mohan as director of the Company Director, liable to retire by rotation

7. Appointed Mrs Dimple Gupta as director of the Company, liable to retire by rotation

8. Reappointed M/s K K Kapoor & Associates, Chartered Accountants as Statutory Auditor.

9. Re-appointment of Sh Varinder Gupta as Managing Director of the Company for next five year w.e.f. Ist September, 2007.

28th August 2007
CONVENING OF ANNUAL GENERAL MEETING ON 22ND SEPT 2007

The Annual General Meeting of the Company will be held on Saturday ,the 22nd day of September 2007 at 10 AM at Registered Office of the Company i.e. Trident Complex, Raikot Road, Barnala interalia to consider the following:
1 Adoption of the audited Balance Sheet of the Company as at 31st March 2007 and Profit and Loss Account of the Company for the year ended .on that date alongwith the Reports of the Auditors and the Directors thereon
2 Appointment of Directors in place of Sh. Varinder Gupta, Dr. M A Zahir, Sh. Yogesh Goel, Dr.(Mrs) H K Bal, Sh Chandra Mohan and Mrs Dimple Gupta who retires by rotation being eligible offer themselves for re-appointment..
3 Appointment of M/s K K Kapoor & Associates, Chartered Accountants , the retiring Auditor being eligible offer themselves for re-appointment.
4 Re-appointment of Sh Varinder Gupta as Managing Director for next five year w.e.f 1st September 2007.
Notice of the meeting has been despatched to all members of the Company at their registered address

21st August 2007
OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 21.08.2007

The Share Allotment Committee of the Board in its meeting held on 21.08.2007 has approved the allotment of 57,00,000 warrants on preferential basis carrying an option to the holder of such warrants to subscribe to one equity share of 10/- (Rupees ten) at a premium of 32/- per share for every warrant held, within 18 months from the date of allotment of the warrants,

10th July 2007
UPDATES

The Company has completed the expansion of its Ibuprofen plant and now the installed capacities of Ibuprofen plant stands increased to 3600 TPA per annum from existing 1800 TPA per annum. The plant has been set up as per Regulated Markets parameters i.e USFDA, UKMHRA, etc.

The company has recently expanded the capacities of its Acetic Acid Plant from 30000 TPA to 50000 TPA, Ethyl Acetate Plant from 18000 TPA to 33000 TPA & Acetic Anhydride Plant from 7500 TPA to 12000 TPA. In addition, the company has also set up a 4 MW Co-Generation Plant to meet out its energy requirements.

23rd June 2007
CONVENING OF EXTRA- ORDINARY GENERAL MEETING ON 23-07-2007

The Extra-ordinary General Meeting of the Company will be held on Monday, 23rd day of July, 2007 at 10.00 AM at the Registered Office of the Company i.e. Trident Complex, Raikot Road, Barnala interalia to consider the following:

1.To increase of Authorised Share Capital of the Company from 20 crores to 30 crores .
2. To consider and Issue of Securities to Qualified Institutional Buyers (QIBs) in accordance with the provisions of Chapter XIII A of SEBI (DIP) Guidelines,2000 for an amount not exceeding 50 crores (Rupees Fifty Crores)
3. To c onsider and issue of securities in the international market upto United State Dollars 10 (ten) Millions.
4. To cosider and issue of 57,00,000 warrants, carrying an option to the holder of such warrants to subscribe to one equity share of 10/- for every warrant held, within 18 months from the date of allotment of the warrants at the price to be fixed as per SEBI Guidelines to the Promoters and Other Strategic Investors on the Preferential basis.

Notice of the meeting has been despatched to all members of the Company at their registered address.

23rd June 2007
OUTCOME OF THE BOARD MEETING HELD ON 23.06.2007

The Board of Directors in its meeting held on 23.06.2007 has approved the following matters:
1. Allotment of 15,00,000 Equity Shares to M/s Mayadevi Polycot Limited (Promoter) and 11,00,000 Equity Shares to M/s Chamunda Traders Private Limited (Strategic Investor) face value of 10/- each at the Price of 42/- per share on Preferential basis.
2. Re-appointment of Sh. Varinder Gupta as Managing Director of the Company
3. Annual Accounts for the Financial Year ended 31st March, 2007.
4. Audited Financial Results for the quarter/year ended 31st March, 2007
5. Issue of Securities to Qualified Institutional Buyers (QIBs) in accordance with the provisions of Chapter XIII A of SEBI (DIP) Guidelines,2000 for an amount not exceeding 50 crores (Rupees Fifty Crores).
6. Raising of sources through issue of securities in the international market upto United State Dollars 10 (ten) Millions
7. Increase in the Authorised Share Capital of the Company from 20 crores to 30 crores
8. Issue of 57,00,000 warrants, carrying an option to the holder of such warrants to subscribe to one equity share of 10/- for every warrant held, within 18 months from the date of allotment of the warrants at the price to be fixed as per SEBI Guidelines to the Promoters and Other Strategic Investors on the Preferential basis.
9. Convening of Extra-ordinary General Meeting on 23.07.2007

10th February 2007
TRIDENT QUALITY PIONEER AWARD WON BY INDUSTRIAL ORGANICS LTD.

Industrial Organics Limited has won "Trident Quality Pioneer Award" under the medium-scale business category for Excellence in Quality at the '6th North-West QualTech Convention & Awards 2006' organized by PTU's Gian Jyoti School of TQM & Entrepreneurship, Mohali, on 10th Feb'07. North-West QualTech awards have been instituted for recognizing outstanding Quality Improvement Initiatives of Industry & Business houses in the Northern Region of the country. The awards were presented by Dr. Surinder Kapoor, CMD, Sona Koyo Steering Systems Ltd. and Dr. S.K. Salwan, Vice-Chancellor, Punjab Technical University.

14th December 2006
IOL CHEMICALS AND PHARMACEUTICALS LTD. HAS BEEN AWARDED

IOL Chemicals and Pharmaceuticals Limited has been awarded the ‘National Energy Conservation Award-2006’(2nd Prize) in Chemical Sector by the Ministry of Power, Govt. of India consecutively.

5th December 2006
CHANGE OF THE NAME OF THE COMPANY

The name of the company has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Limited, pursuant to the provisions of section 21 of the Companies Act, 1956, with the approval of Central Government with effect from 05.12.2006.